Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,9909,351,0.77 [0.42-1.41],0.3908718075309413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,9624,345,1.01 [0.83-1.23],0.942255391544422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,11354,418,1.05 [0.90-1.23],0.5452934296416008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,9580,341,0.92 [0.67-1.25],0.5937926224042993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,11292,411,1.05 [0.90-1.22],0.5536486645429105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,11354,418,1.02 [0.90-1.15],0.7658408603051551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,9907,357,1.05 [0.98-1.13],0.1475402030225642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,9580,341,1.05 [0.90-1.23],0.5496436521561994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",11123,409,0.96 [0.86-1.07],0.478185848986256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",9747,351,1.03 [0.89-1.20],0.6772985989964408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",9898,356,1.07 [0.96-1.19],0.2446933463830944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,11298,412,0.98 [0.71-1.36],0.8948280594405376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,9907,357,1.14 [0.78-1.65],0.5054581024143847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,11200,414,0.89 [0.75-1.06],0.1866356058467414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,9673,340,0.97 [0.71-1.32],0.8341812002402119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,9866,351,1.02 [0.94-1.12],0.6053364015323841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,11410,413,1.04 [0.88-1.23],0.6655088062801671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,9609,341,1.03 [0.82-1.29],0.8092946835142566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,11444,421,0.87 [0.67-1.12],0.2795825360745996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,11500,427,0.97 [0.86-1.11],0.675818939859828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,9864,357,1.23 [0.97-1.57],0.0888303496967673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,9609,341,0.99 [0.90-1.10],0.9105945098842112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,9580,341,0.88 [0.64-1.21],0.4434420725199717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",11200,414,0.91 [0.73-1.12],0.3663210031036489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,9580,341,1.07 [0.91-1.25],0.42238891481773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,11217,413,0.90 [0.66-1.21],0.470780535042187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,11309,412,0.93 [0.63-1.37],0.7156745361088828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,11410,413,0.87 [0.75-1.00],0.0464441544163144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,9580,341,0.93 [0.77-1.12],0.4332543457825693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,9642,339,1.07 [0.91-1.25],0.4225869412510903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,11557,426,0.93 [0.73-1.19],0.5788089465383119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,11343,413,0.66 [0.54-0.82],0.0001338994670379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,9609,341,1.05 [0.77-1.44],0.7509012568170496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,11200,414,1.06 [0.80-1.41],0.6705776700303756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,11330,413,0.99 [0.77-1.27],0.9391046077885468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,11557,426,1.03 [0.80-1.31],0.8421595097895654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,11502,426,0.95 [0.71-1.28],0.7374236012437454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,9866,351,0.82 [0.58-1.15],0.2519800838482643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,9609,341,1.24 [0.90-1.71],0.1913092117746662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,11545,425,1.10 [0.76-1.60],0.6002279461376584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,11354,418,0.98 [0.79-1.21],0.8467248930500227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,11200,414,0.86 [0.65-1.14],0.2992645603505607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,9609,341,0.91 [0.69-1.22],0.5429022351732677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,11429,424,1.09 [0.90-1.31],0.3883380862065591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,9911,356,0.93 [0.67-1.27],0.6332033387307998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,9624,345,1.08 [0.71-1.64],0.7284636094420969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,9898,356,0.82 [0.64-1.06],0.1369595657948198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,11123,409,0.93 [0.70-1.24],0.635524621475521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,9673,340,1.10 [0.95-1.28],0.2036093110799202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,11309,412,0.88 [0.67-1.15],0.3406601059821178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,9673,340,1.02 [0.79-1.32],0.8826753251984814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,9866,351,0.95 [0.79-1.15],0.6120805018095119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,11447,423,0.64 [0.47-0.88],0.0061785531305419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,11485,424,0.71 [0.52-0.95],0.022648536640116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,9898,356,1.01 [0.69-1.47],0.9627009320875296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,11354,418,0.84 [0.72-0.98],0.0246443423683512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,11410,413,1.07 [0.78-1.47],0.691033330583112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,9574,343,0.96 [0.82-1.13],0.6500837094780522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,9673,340,0.91 [0.80-1.05],0.2034264547208771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,11200,414,0.92 [0.83-1.03],0.1453037114570801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,9909,351,1.19 [1.02-1.38],0.0251030382556572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,11511,427,1.10 [0.79-1.53],0.5767575105437375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,9580,341,0.95 [0.81-1.11],0.5271719026534832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,9673,340,1.05 [0.93-1.19],0.4262824899266006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFM,Afamin,9909,351,1.11 [0.67-1.86],0.681081148252417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,11288,412,1.20 [1.05-1.36],0.0084289687676335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,9574,343,1.07 [0.95-1.20],0.2900980421566856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,11365,418,0.76 [0.61-0.95],0.0157396551896229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,11083,410,1.04 [0.95-1.14],0.4073515920942488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,11111,409,0.94 [0.80-1.09],0.383935266073361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,11447,423,0.73 [0.56-0.96],0.0262795940378814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,11557,426,0.94 [0.80-1.11],0.460927130436378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,9907,357,1.27 [0.79-2.05],0.3245576465883522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,11410,413,0.91 [0.81-1.02],0.1096254930994753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,11410,413,1.03 [0.91-1.17],0.6537567159494764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,9624,345,0.80 [0.58-1.12],0.1916602378666814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,9624,345,0.97 [0.69-1.38],0.8829609020333545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,9864,357,1.06 [0.91-1.23],0.4508168052144987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,9907,357,1.03 [0.71-1.50],0.8705931406353558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,11378,417,0.91 [0.82-1.01],0.0696224534193021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",9644,346,0.99 [0.88-1.12],0.9182344670406416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,11123,409,1.03 [0.88-1.22],0.701303856260056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,9624,345,0.89 [0.73-1.10],0.2743129956267863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",11338,416,1.00 [0.93-1.09],0.9274806656965554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,11410,413,0.94 [0.82-1.08],0.3886894407866157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",9874,353,1.05 [0.95-1.15],0.3234400633559674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,9673,340,1.39 [0.89-2.16],0.1440127363463856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,11123,409,0.99 [0.88-1.12],0.892358798580843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,9644,346,0.93 [0.78-1.10],0.3895853707536113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,11200,414,1.01 [0.85-1.20],0.9142115740815012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,9609,341,0.89 [0.76-1.05],0.1717484591914827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,11164,413,1.02 [0.89-1.17],0.7593572000335922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,9883,356,1.05 [0.97-1.14],0.1875494062461992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,11060,406,1.13 [0.97-1.31],0.1038432682798199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,11545,425,1.27 [0.81-1.99],0.2964319273919893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,11395,417,0.84 [0.71-0.99],0.0385097328179488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",9864,357,1.06 [0.88-1.29],0.5317956122910935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",11395,416,0.90 [0.79-1.04],0.1538873209273696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",9883,356,1.10 [0.89-1.35],0.3927275791480761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,9747,351,0.85 [0.66-1.09],0.1990802796374269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,9609,341,1.02 [0.94-1.11],0.6275477709830899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",11354,418,0.96 [0.89-1.04],0.3160930718850798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,11217,413,0.83 [0.59-1.18],0.3048724396555043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,11495,426,0.83 [0.53-1.30],0.4205357753674662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,9911,356,0.89 [0.61-1.31],0.5521697177355418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,11164,413,0.90 [0.78-1.04],0.1586736875354331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,9644,346,0.98 [0.80-1.20],0.8617563100328177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,11354,418,0.86 [0.59-1.25],0.4195842514013996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,11217,413,1.04 [0.86-1.25],0.7156155579971646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,9673,340,1.07 [0.81-1.41],0.6255926556218886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,9822,355,1.11 [0.92-1.35],0.2699420272741895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,9874,353,0.98 [0.85-1.13],0.7843109592417241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,9287,334,0.91 [0.74-1.13],0.4078385297306723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,10992,402,0.96 [0.79-1.16],0.64011125608328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,10652,391,1.00 [0.83-1.21],0.9984466398698572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,11377,413,0.88 [0.68-1.16],0.3671192455797692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,11367,419,1.02 [0.92-1.13],0.6794588678198967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,11511,427,0.83 [0.65-1.06],0.1377870560874106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,11227,405,1.17 [0.86-1.60],0.3150052820493651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,11402,421,0.87 [0.70-1.08],0.2166845810928541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,11417,414,0.82 [0.63-1.07],0.1398774857225112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,11430,420,1.00 [0.82-1.21],0.985476414011322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,11511,427,0.96 [0.76-1.22],0.7577549351933215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,9580,341,0.98 [0.84-1.14],0.7778250098842776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,9609,341,1.07 [0.94-1.21],0.3218615913923091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,9552,341,0.79 [0.65-0.96],0.0197108057278651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,11123,409,0.90 [0.77-1.06],0.2220806033690052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,9624,345,0.83 [0.61-1.13],0.2391515160888382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,11437,416,1.01 [0.73-1.39],0.9703712160704048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,9621,338,1.05 [0.85-1.31],0.6427402891618936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,11164,413,1.04 [0.93-1.16],0.5320263267630996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,11385,417,1.06 [0.93-1.21],0.3951172328621843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,9495,339,0.95 [0.82-1.11],0.5244484956776949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,11502,426,1.06 [0.94-1.20],0.3237528089849729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,11359,413,1.06 [0.95-1.19],0.3040812592356308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,11126,410,0.85 [0.63-1.15],0.2890063152503811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],11217,413,0.88 [0.73-1.05],0.1409637416658719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,11451,416,0.79 [0.59-1.06],0.1143922511725538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,9864,357,1.09 [0.96-1.23],0.1709774235347929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,9644,346,1.12 [0.92-1.38],0.2658269826343098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,9866,351,1.07 [0.94-1.22],0.2908926991752991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,9874,353,1.11 [0.91-1.36],0.3142855668063671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,11354,418,0.94 [0.77-1.13],0.4978352086079524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,9830,348,1.10 [0.79-1.52],0.5719680194781541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,11485,426,1.00 [0.86-1.16],0.9995043085517722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,11410,413,0.90 [0.76-1.07],0.2345160294885943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,9909,351,1.26 [0.88-1.80],0.2131773285907093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,9907,357,1.01 [0.83-1.25],0.8887330710036366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,9909,351,0.78 [0.57-1.07],0.1229271879073989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,9907,357,1.37 [0.88-2.12],0.1630445589745866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,9624,345,0.86 [0.68-1.10],0.2254013530028799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,9893,350,1.19 [0.91-1.56],0.1995379231398839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,9455,333,1.17 [0.93-1.48],0.187903182797063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,9909,351,1.01 [0.86-1.18],0.9448012892995252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,9907,357,1.05 [0.75-1.45],0.7926417841427538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,11395,417,1.03 [0.81-1.31],0.8124255637715083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,9907,357,1.15 [0.97-1.35],0.0987886925086643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,11439,415,1.15 [0.84-1.58],0.3737545521698013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,11379,417,0.99 [0.87-1.12],0.8357588286677347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,9673,340,1.06 [0.96-1.16],0.2274521204026783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,11320,412,1.06 [0.88-1.28],0.5267274460591282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,9747,351,1.03 [0.88-1.21],0.6967073737112625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,11354,418,0.63 [0.49-0.82],0.0006640254389611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,9866,351,1.02 [0.93-1.13],0.6089703075148467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,9883,356,1.10 [0.95-1.27],0.190863658269922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,11347,420,0.88 [0.74-1.04],0.1284858205639728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",9864,357,1.24 [1.00-1.54],0.0514112868822757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,11123,409,1.15 [0.96-1.39],0.1309090350613161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,11123,409,1.01 [0.88-1.17],0.8563394943961776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,9747,351,1.11 [0.89-1.40],0.3562363993627455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,9673,340,1.07 [0.94-1.21],0.3022571741255297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,9552,341,1.01 [0.88-1.16],0.8858794743415241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,9874,353,0.99 [0.89-1.11],0.8989847811367705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,9883,356,0.98 [0.88-1.09],0.7493150167963712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,11410,418,1.02 [0.94-1.11],0.6004128779585411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,9574,343,1.00 [0.87-1.16],0.981534158553318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,9574,343,0.75 [0.57-0.99],0.0457508581774278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,11164,413,0.96 [0.77-1.20],0.7334066846639677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,9580,341,1.00 [0.85-1.16],0.9548312330630412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,9580,341,1.03 [0.80-1.33],0.8178360860811031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,9574,343,1.17 [1.00-1.37],0.0494703174170038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,11217,413,1.01 [0.81-1.26],0.933690231715089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,9580,341,0.95 [0.76-1.19],0.6592827945899239
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,11395,417,1.06 [0.88-1.28],0.5415952413275762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,11354,418,1.04 [0.89-1.21],0.6382931210554769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,11451,416,0.87 [0.67-1.12],0.2737374703161596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,9574,343,0.92 [0.76-1.11],0.38380067182674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,11217,413,1.11 [0.92-1.33],0.2701251421109176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,9828,355,0.95 [0.76-1.18],0.6243777277451134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,11330,413,1.00 [0.85-1.18],0.9884758153210964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,11330,413,0.89 [0.66-1.21],0.4647342206846737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,9907,357,0.72 [0.48-1.07],0.1047343041528136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,9898,356,0.95 [0.66-1.38],0.7921033285422243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,9883,356,1.08 [0.93-1.25],0.3304584822680713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,9624,345,1.05 [0.94-1.16],0.3942766296569743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,9580,341,0.90 [0.79-1.03],0.133524199696786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,11164,413,0.92 [0.79-1.07],0.2660367947796146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,9552,341,1.16 [0.85-1.57],0.345541090521404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,9866,351,1.03 [0.92-1.16],0.5864983166552378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,11123,409,1.04 [0.89-1.20],0.6437336349247503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,11429,424,1.05 [0.94-1.18],0.3967643304498899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,9580,341,0.84 [0.65-1.07],0.1621536679199118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,9580,341,1.02 [0.72-1.43],0.9177861656618396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,9580,341,1.01 [0.78-1.31],0.945897639567098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,9552,341,0.84 [0.64-1.10],0.1978653081112875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,9580,341,1.03 [0.88-1.20],0.7353663976576263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",9580,341,0.90 [0.72-1.13],0.3814033978548896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",11447,423,1.02 [0.94-1.10],0.6009499277649898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",11164,413,1.25 [1.01-1.54],0.0367889010159103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,11123,409,0.99 [0.80-1.24],0.946513779069059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,11354,418,1.10 [0.80-1.51],0.5481417292316167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,11145,412,1.08 [0.95-1.23],0.2244038958862902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,9624,345,1.09 [0.95-1.25],0.2267950486460151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,9580,341,0.85 [0.76-0.95],0.0051053979401264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,9866,351,0.91 [0.63-1.33],0.6337466043250626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",9909,351,0.55 [0.29-1.02],0.0566071388323833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,11164,413,1.10 [0.97-1.24],0.1322642766416421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,9574,343,1.06 [0.97-1.17],0.1984362486836225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,9883,356,1.16 [0.95-1.41],0.1375697499927044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,9874,353,1.09 [0.93-1.28],0.3012953670229742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,11410,418,1.04 [0.95-1.13],0.4229634450247013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,11451,416,0.90 [0.65-1.24],0.5125101009884396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,9883,356,1.10 [0.93-1.32],0.2684945768345617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,11086,413,0.96 [0.85-1.08],0.464852089451759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,9909,351,0.89 [0.63-1.27],0.5170562644261869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,9580,341,1.11 [0.68-1.82],0.6848272705794065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",9624,345,0.82 [0.62-1.09],0.1728101218335666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",11447,423,0.88 [0.64-1.21],0.4319205788222814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",11395,417,0.92 [0.65-1.32],0.6647793348511266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,9609,341,1.16 [0.84-1.61],0.3646865115479998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,11410,418,1.04 [0.93-1.17],0.4883092942406053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,11309,412,1.08 [0.86-1.35],0.4966112661010328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,9609,341,1.07 [0.88-1.31],0.5070431371043485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,11200,414,1.29 [1.03-1.63],0.0286388958433101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,11123,409,1.02 [0.89-1.17],0.7613095211239762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,11123,409,1.51 [1.13-2.01],0.0050724184583163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,11410,418,1.02 [0.94-1.11],0.6632211677265207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,9874,353,1.00 [0.87-1.15],0.9937895049786294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,9644,346,0.89 [0.77-1.03],0.1267712716994921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,11145,412,1.09 [0.99-1.20],0.0705567475783992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,11395,417,0.88 [0.61-1.28],0.5098356953846437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,11330,413,1.14 [0.89-1.48],0.3042826951697301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",9898,356,1.21 [0.88-1.66],0.2413162806984934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",9574,343,1.06 [0.87-1.29],0.5669462259341902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,9727,346,1.18 [0.80-1.75],0.4034131503238168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,9866,351,1.07 [0.89-1.29],0.4651050267117036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,9874,353,1.04 [0.94-1.15],0.492141812199126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",11410,418,0.90 [0.74-1.10],0.3118061099914945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,9609,341,0.84 [0.69-1.02],0.0727559098002058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,9552,341,1.06 [0.92-1.22],0.4121577801989032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,9864,357,1.08 [0.88-1.33],0.4510389883503501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,11410,418,1.01 [0.92-1.11],0.8635687679041423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,9911,356,1.00 [0.88-1.12],0.9678710263871648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,9624,345,1.16 [0.98-1.38],0.0807779853526095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,9552,341,1.05 [0.84-1.30],0.6905439227228476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,9911,356,0.95 [0.85-1.07],0.4319171989148934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,11107,408,1.03 [0.95-1.10],0.4832844521111241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,9574,343,1.02 [0.88-1.18],0.7926966913367162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,9580,341,0.97 [0.65-1.45],0.8880923038999735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,11410,418,1.08 [0.95-1.23],0.2249368062831963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,11395,417,1.07 [0.97-1.17],0.1920483528994819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,11123,409,1.05 [0.91-1.20],0.5121377214940123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,11545,425,1.03 [0.78-1.36],0.8261186910904335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,9609,341,1.09 [0.85-1.41],0.4831890869331522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,9574,343,1.01 [0.88-1.16],0.886441403746765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,9874,353,1.30 [1.03-1.63],0.0256050933673793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,11395,417,0.95 [0.84-1.09],0.4913340846106817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,9673,340,1.33 [0.91-1.95],0.1388244345585362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,11309,412,1.08 [0.90-1.29],0.4337370718988652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,11179,413,0.91 [0.73-1.14],0.4186760880453279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,9673,340,1.01 [0.63-1.61],0.965093908170644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,9898,356,1.35 [1.04-1.77],0.0263141908233444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,9609,341,1.05 [0.83-1.32],0.6860254462922386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,11200,414,1.45 [0.99-2.12],0.0559821846829689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,9574,343,0.97 [0.80-1.18],0.7791465349128964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,9624,345,1.11 [0.91-1.35],0.2909567114277995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,9285,336,0.98 [0.89-1.08],0.6864157637778852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,11380,420,0.98 [0.86-1.12],0.7363908523304306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,9883,355,0.95 [0.80-1.13],0.5949770168862271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,9756,346,1.07 [0.97-1.18],0.1533052856678934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,9747,351,1.23 [0.89-1.70],0.2098103224211712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,9574,343,0.97 [0.71-1.31],0.8224487097754866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,9580,341,1.12 [0.93-1.35],0.2198660404962207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,9580,341,1.10 [0.82-1.46],0.5262182335297421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,11164,413,1.14 [0.94-1.38],0.1936399450478366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,9574,343,0.85 [0.64-1.14],0.2849299229152485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,9883,356,1.25 [0.97-1.60],0.0789569887391558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSG,Basigin,11536,426,1.09 [0.70-1.72],0.695933346689255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSND,Barttin,9552,341,1.10 [0.81-1.50],0.5391766697365026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,11520,426,0.90 [0.76-1.07],0.2468795895277242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,11520,426,0.92 [0.77-1.09],0.3338699383680454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,11123,409,1.07 [0.96-1.20],0.219410096636487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,9909,351,0.92 [0.56-1.52],0.7528526821830936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,9552,341,0.99 [0.87-1.12],0.8445654919279807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,9845,356,1.05 [0.81-1.36],0.7279397664416707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,11447,423,0.72 [0.51-1.02],0.0669733334794038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,11410,418,1.18 [0.93-1.50],0.1703443854473475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,9552,341,0.96 [0.72-1.27],0.7655347687621241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,11164,413,0.93 [0.81-1.07],0.3343996096782305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,9580,341,0.97 [0.69-1.35],0.8562727264928434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,11500,425,0.87 [0.59-1.29],0.4958892360597502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",9883,356,1.04 [0.89-1.20],0.6276433425902681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,9609,341,0.88 [0.68-1.12],0.2951727638933064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,11451,416,0.91 [0.74-1.12],0.3757010085143265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,9673,340,1.25 [0.93-1.68],0.1388484187692257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,9883,356,1.13 [0.83-1.55],0.4370991089788546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,9659,340,0.93 [0.75-1.14],0.4636831845875444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,9909,351,1.18 [0.70-1.99],0.5252691103059943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,9893,351,0.81 [0.49-1.36],0.4358686862857909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,9909,351,1.07 [0.66-1.73],0.7922008881465286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,11439,415,0.83 [0.60-1.17],0.2913883548015422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,11145,412,0.95 [0.77-1.18],0.6494704027344094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,9644,346,1.11 [0.93-1.32],0.2429470881223703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C3,Complement C3,9424,327,0.85 [0.65-1.11],0.2405311727912397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,11429,424,1.06 [0.84-1.33],0.6407535371275654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C5,Complement C5,9909,351,1.20 [0.61-2.36],0.5929898956771094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,9682,339,1.09 [0.78-1.52],0.6068449297392875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,9874,353,1.34 [0.97-1.85],0.0762709773341977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,9909,351,1.06 [0.75-1.48],0.745349816886119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,9907,357,1.01 [0.85-1.21],0.8773560751015433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,9866,351,0.98 [0.86-1.11],0.7139259550888322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,11163,400,0.89 [0.76-1.04],0.1466976551548818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,11123,409,0.91 [0.67-1.24],0.5607156858045204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,11354,418,1.00 [0.76-1.32],0.9903413737053152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,11275,410,1.05 [0.97-1.14],0.2580929718091504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,11511,427,1.10 [0.86-1.39],0.4457207784141681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,11365,416,0.94 [0.83-1.07],0.3805728207304331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,11528,425,1.00 [0.87-1.15],0.97488974002675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,11545,425,1.02 [0.71-1.46],0.922890699019708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",11200,414,0.92 [0.84-1.02],0.1204294545707707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,11354,414,1.07 [0.93-1.23],0.3486784870510333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,9747,351,0.93 [0.68-1.27],0.6397776770654136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,9609,341,0.88 [0.58-1.34],0.5567928729358214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,11511,427,0.95 [0.78-1.15],0.5872327412673979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,9644,346,1.02 [0.87-1.19],0.8261126173880963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,9574,343,0.97 [0.69-1.37],0.8618499715793249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,9580,341,0.95 [0.79-1.16],0.6249821359686225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,9574,343,1.15 [0.98-1.36],0.0771201847770653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,9883,356,1.10 [0.97-1.23],0.1249648763672675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,9656,340,1.05 [0.95-1.17],0.300781657379627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,9644,346,1.25 [1.01-1.56],0.042927183885375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,11354,418,1.01 [0.83-1.24],0.9138690628532372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,11164,413,0.91 [0.67-1.25],0.5723171896776288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,11311,412,0.83 [0.73-0.95],0.0072228530600545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,9874,353,0.89 [0.67-1.17],0.4014880361296691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,11482,427,1.04 [0.96-1.13],0.3652950724530446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,9624,345,1.04 [0.90-1.18],0.6153638467117639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,9580,341,1.08 [0.83-1.40],0.5773605060236013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,11123,409,0.94 [0.77-1.14],0.5367802755505324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,9644,346,0.98 [0.80-1.19],0.803506662564432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,9883,356,1.05 [0.96-1.16],0.2680438424667112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,11373,413,0.99 [0.63-1.54],0.9515444010538768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,11341,421,0.91 [0.78-1.05],0.1869473642760238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,9864,357,1.23 [0.99-1.54],0.0674172193149528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,9874,353,0.93 [0.82-1.05],0.2462526211787394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,11164,413,1.00 [0.84-1.19],0.99812330026759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,9644,346,1.15 [0.92-1.44],0.218048913044081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,11164,413,0.89 [0.78-1.02],0.0951269442979106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,11164,413,1.10 [0.97-1.24],0.1231040455018656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,11410,418,1.07 [0.95-1.21],0.2647593359122533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,11545,425,1.04 [0.94-1.14],0.430552773683293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,9747,351,1.02 [0.96-1.08],0.5046245753547243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,9874,353,1.06 [0.94-1.19],0.3307589495129401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,11484,426,1.01 [0.89-1.16],0.8371686776705666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,9609,341,1.03 [0.87-1.21],0.7587850803623495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,9580,341,0.70 [0.52-0.92],0.0122501394157041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,9762,351,0.99 [0.82-1.20],0.9493237525590676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,11400,413,0.89 [0.79-1.01],0.0758872970399768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,9574,343,0.98 [0.87-1.10],0.7334583972973664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,11511,427,0.98 [0.75-1.28],0.8890311910812861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,9624,345,0.83 [0.67-1.03],0.09730539798104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,9580,341,0.80 [0.58-1.09],0.161857947078852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,11330,413,1.06 [0.95-1.19],0.3010755487091059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,9874,353,1.07 [0.91-1.27],0.3916730575353874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,9864,357,1.15 [0.95-1.40],0.1411444468869326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,9644,346,1.03 [0.72-1.47],0.8713869478803509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,9883,356,1.10 [0.98-1.24],0.095867243255767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,11410,413,0.88 [0.67-1.16],0.3627725293054611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,9624,345,0.86 [0.72-1.01],0.0699225852263261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,11557,426,0.97 [0.77-1.22],0.795261345338335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,11538,426,0.95 [0.84-1.08],0.4609711044017145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,11377,413,1.01 [0.82-1.25],0.9221093915698756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,11545,425,1.02 [0.84-1.24],0.8425909978659049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,11545,425,0.99 [0.84-1.16],0.9149454779539724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,11365,418,0.92 [0.84-1.02],0.1082954750667584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,11260,408,0.87 [0.76-1.00],0.0514035993055226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,11520,426,0.94 [0.86-1.02],0.1441687287990174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,11309,412,0.90 [0.76-1.06],0.2044224420628098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,11557,426,0.94 [0.84-1.05],0.2513981113980474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,11447,423,0.99 [0.79-1.26],0.9648323770869064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,11260,414,0.88 [0.74-1.05],0.1642020064951929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,11447,423,0.81 [0.66-0.99],0.0378428529926894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,11430,420,1.02 [0.92-1.14],0.6671525719902628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,11557,426,0.97 [0.81-1.15],0.6913935822586215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,11410,418,0.93 [0.85-1.03],0.173372328184258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,11410,413,0.91 [0.80-1.04],0.1763888389617668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,11374,415,1.06 [0.92-1.22],0.4383655163596029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,11410,418,0.92 [0.79-1.07],0.2624240320010036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,11408,422,0.94 [0.82-1.09],0.4188715501398166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,11451,416,1.00 [0.92-1.09],0.972593347658516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,11410,418,0.94 [0.80-1.11],0.4693317846377765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,11495,426,1.01 [0.88-1.16],0.91192210201835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,11338,417,0.92 [0.82-1.04],0.1786489464426029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,11398,419,1.02 [0.88-1.18],0.7636666713020455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,11521,425,0.90 [0.68-1.19],0.4708852018847589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,11511,427,1.16 [0.94-1.43],0.1757955619943029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,11395,417,0.96 [0.76-1.21],0.7413744588242535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,9747,351,1.19 [0.90-1.58],0.2153349627710559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,9609,341,1.03 [0.93-1.14],0.5503562347458508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,11330,413,1.01 [0.84-1.21],0.915558903733832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,11123,409,1.11 [0.91-1.35],0.3041739889933406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,9866,351,0.93 [0.73-1.17],0.5260970983332083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,11395,417,0.86 [0.67-1.11],0.240578635039139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,11181,404,0.87 [0.69-1.08],0.2069806115149359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,11557,426,0.85 [0.70-1.03],0.0928351128639295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,11451,416,0.91 [0.74-1.11],0.3440594104877054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,11395,417,0.98 [0.71-1.37],0.926697673705592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,9644,346,1.17 [0.89-1.55],0.2642136620073635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,11380,417,0.97 [0.91-1.04],0.4039443892422483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,11429,424,1.18 [0.83-1.69],0.3605177633064976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,9580,341,0.93 [0.70-1.25],0.6497504655763479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,11410,418,1.04 [0.75-1.45],0.8151999962118035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,11365,417,0.91 [0.71-1.16],0.4407266297127683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,11145,411,0.87 [0.69-1.10],0.253983369207139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,11425,419,1.25 [1.01-1.55],0.0390030563518946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,11557,426,1.05 [0.85-1.29],0.6661786651358468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,9609,341,1.12 [0.88-1.43],0.3365844718292899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,11557,426,1.08 [0.78-1.48],0.6439946316317351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,9911,356,1.00 [0.78-1.29],0.9887147907253314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,11429,424,0.84 [0.67-1.05],0.1290073920907684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,11330,413,0.85 [0.65-1.13],0.2655628896130942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,11384,418,0.96 [0.75-1.23],0.752855081940594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,11123,409,0.95 [0.73-1.22],0.6710175930723685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,11410,413,1.02 [0.88-1.17],0.8283176273130286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,9673,340,0.97 [0.68-1.38],0.8439584252919534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,11520,426,0.77 [0.60-0.99],0.0385978029649244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,11478,425,0.78 [0.63-0.98],0.0356992778427422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,11511,427,0.88 [0.77-1.00],0.046374491684295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,11395,417,0.94 [0.74-1.20],0.6326465158649179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,11354,418,0.83 [0.61-1.12],0.225770333334443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,11429,424,0.89 [0.80-0.99],0.0311143980632212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,11482,425,1.00 [0.70-1.43],0.996459954381248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,9609,341,0.91 [0.73-1.14],0.4096563280928954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,11354,418,0.92 [0.69-1.23],0.5857058607993876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,9574,343,1.17 [0.88-1.56],0.2733632377755658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,9747,351,1.15 [0.89-1.48],0.2876822017113069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,9609,341,0.98 [0.87-1.10],0.7104798346445721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,11389,417,0.93 [0.67-1.28],0.6412480679669161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,11391,419,1.05 [0.89-1.25],0.5448286275065941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,11557,426,0.99 [0.89-1.10],0.8880137750246556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,11345,412,1.03 [0.76-1.40],0.8435285324553974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,11430,420,0.92 [0.69-1.24],0.5861341040967478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,11495,426,1.02 [0.79-1.32],0.8606116133237094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,11021,400,0.85 [0.59-1.23],0.3996499904021413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,11361,418,0.69 [0.42-1.13],0.1375511478507131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,10997,406,0.69 [0.44-1.09],0.113594475993126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,9863,348,0.88 [0.71-1.10],0.2581725920169431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,11536,426,1.01 [0.85-1.18],0.94477086197217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,11309,412,1.04 [0.88-1.24],0.6512968078525063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,11346,411,1.06 [0.96-1.17],0.2830507090745099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,9595,341,1.00 [0.78-1.29],0.9831059079761328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,11410,418,0.99 [0.82-1.21],0.9557706872324948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,9673,340,0.92 [0.71-1.20],0.5423416161520564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,11520,426,0.67 [0.52-0.88],0.0031559229903864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,11557,426,0.90 [0.73-1.11],0.3154328810579515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,9898,356,0.84 [0.61-1.16],0.2799868648212874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,9747,351,1.16 [0.95-1.42],0.150449464478577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,11410,418,0.78 [0.59-1.03],0.0762792124877219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,11410,418,1.35 [1.03-1.77],0.0276991028768601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,9866,351,1.13 [0.80-1.59],0.4879391079570871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,11520,426,0.96 [0.81-1.15],0.6831907544038003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,10962,394,0.80 [0.58-1.08],0.145295007634021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,11395,417,0.86 [0.54-1.37],0.5190376815171323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,11395,417,0.84 [0.59-1.20],0.344253037886189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,9884,355,0.88 [0.71-1.09],0.2458761233930697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,9874,353,1.04 [0.66-1.63],0.8712087498850833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,9552,341,1.03 [0.88-1.21],0.7420234148569714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,9552,341,1.20 [0.96-1.50],0.1034966380424507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,9844,351,1.08 [0.94-1.25],0.2706551575401779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,11123,409,1.06 [0.92-1.22],0.4441091827437757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,11429,424,1.05 [0.95-1.17],0.3038045433256011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,9866,351,1.05 [0.96-1.16],0.2963331334478445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,11330,413,0.90 [0.76-1.07],0.2320142949429075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,11040,406,0.80 [0.63-1.02],0.0749321569425169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,11501,425,0.90 [0.79-1.03],0.1247476350901797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,11410,413,1.03 [0.91-1.17],0.5986344348967086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,11410,413,0.70 [0.54-0.89],0.0045231609654488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,9747,351,1.07 [0.74-1.56],0.7106002165697956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,9874,353,1.14 [0.79-1.64],0.4832274353773974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,11520,426,0.85 [0.66-1.10],0.2249483369822308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,9574,343,1.00 [0.79-1.27],0.9801338817482572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,11545,425,1.03 [0.77-1.36],0.861782336451179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,11410,413,1.05 [0.84-1.33],0.6544440657784256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,11164,413,1.11 [0.91-1.36],0.2966510973428123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,11354,418,0.98 [0.86-1.11],0.7265787870863314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,11410,413,0.90 [0.73-1.13],0.3678539954252574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,9552,341,0.95 [0.71-1.27],0.7429619424940339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,9883,356,0.93 [0.79-1.11],0.4267021920647112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,9574,343,1.09 [0.90-1.33],0.3564783048207132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,11354,418,1.00 [0.92-1.08],0.9261297412925062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,11354,418,1.02 [0.93-1.12],0.6257273363147939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,11354,418,0.99 [0.75-1.30],0.9307480469606096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,11404,419,0.82 [0.58-1.15],0.246551161776567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,11519,425,1.00 [0.82-1.23],0.9641034683259564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,11412,423,0.74 [0.55-0.99],0.0437255370863588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,9866,351,1.03 [0.91-1.17],0.6136366486826216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,9747,351,1.01 [0.87-1.17],0.8776022800300267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,9866,351,1.02 [0.79-1.32],0.8868060048483648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,9747,351,1.31 [1.07-1.61],0.0094498481534577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,11410,418,0.98 [0.89-1.09],0.7463503449242411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,11123,409,0.90 [0.74-1.08],0.2618771548539631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,10971,406,0.95 [0.82-1.10],0.4839563689463099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,9911,356,0.96 [0.73-1.25],0.7379717821095966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,11200,414,1.02 [0.86-1.21],0.8303567473538324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,9609,341,0.96 [0.72-1.27],0.7528169311953098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,11200,414,0.96 [0.76-1.21],0.7309165561678168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,9911,356,1.04 [0.89-1.22],0.6115904153734898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,11522,425,1.05 [0.91-1.22],0.469730085374287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,9673,340,1.07 [0.73-1.57],0.7193730705508328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,9609,341,0.76 [0.52-1.12],0.1636762791354174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,9574,343,0.97 [0.81-1.17],0.7636689458326408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,9747,351,1.05 [0.87-1.26],0.6096774217225417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,9747,351,1.16 [1.02-1.33],0.0276729229870309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,9580,341,1.01 [0.80-1.29],0.9138297625775564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,9552,341,1.17 [0.94-1.46],0.1512890605393323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,11217,413,0.87 [0.74-1.03],0.1105076848708511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,9624,345,1.07 [0.94-1.22],0.2894090590118715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,11123,409,1.05 [0.93-1.18],0.4168138429025348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,9747,351,1.09 [0.90-1.31],0.3767759657772701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,9552,341,0.96 [0.71-1.29],0.7866903085930105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,11110,409,1.07 [0.95-1.22],0.2610372039618026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,11123,409,1.08 [0.94-1.23],0.2709149404622921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,11164,413,1.07 [0.93-1.24],0.3162951763826752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,11425,422,0.89 [0.81-0.99],0.0344195513019103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,11354,418,1.04 [0.89-1.21],0.6374188373925547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,11354,418,0.99 [0.87-1.12],0.8285619098010333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,11164,413,1.09 [0.96-1.23],0.1918622784008511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,9866,351,1.08 [0.96-1.23],0.2008808188530768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,9740,344,1.01 [0.74-1.40],0.9325196760069484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,11123,409,1.09 [0.92-1.30],0.3216174619675602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,9909,351,1.18 [0.73-1.93],0.4984243499266169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,9349,326,0.95 [0.60-1.51],0.8378057831154461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,9835,348,1.09 [0.90-1.31],0.3677731200503492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,9885,349,1.06 [0.92-1.23],0.4054579586099004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,9781,350,1.25 [0.96-1.62],0.0914306475627153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,9909,351,0.86 [0.51-1.44],0.5649606069084565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,9909,351,0.85 [0.53-1.38],0.5180952426873642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,11395,417,1.02 [0.87-1.18],0.8192534470373358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,9907,357,1.05 [0.80-1.38],0.7223898704395713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,9644,346,1.09 [0.85-1.39],0.5099980370905067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,11410,413,0.90 [0.73-1.11],0.3206881063844733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,11123,409,0.95 [0.82-1.11],0.529930662903348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,9673,340,1.12 [0.89-1.41],0.3494512500678598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",9874,353,0.88 [0.68-1.14],0.330304371955447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,9864,357,1.30 [0.94-1.79],0.111920678007225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,11200,414,1.22 [0.94-1.58],0.1374850842336934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,9911,356,0.92 [0.80-1.06],0.2537906254043843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,11488,425,0.88 [0.71-1.09],0.2294677087230117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,11159,405,0.92 [0.82-1.03],0.1540630450111202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,11453,424,0.96 [0.92-1.01],0.1369910055111201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,11433,416,1.01 [0.76-1.36],0.931442713527917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,9644,346,1.15 [0.98-1.35],0.0952807938995752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,11330,413,1.00 [0.90-1.12],0.963000169704562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,9898,356,1.07 [0.90-1.27],0.449581419992263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,9574,343,1.06 [0.93-1.21],0.3862418096499912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,11430,420,0.74 [0.56-0.97],0.0309039196224832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,11410,413,0.89 [0.74-1.08],0.2375062796877534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,9644,346,1.26 [1.00-1.60],0.0507460031838872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,11429,424,1.03 [0.90-1.18],0.6932632295620664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,9911,356,0.97 [0.81-1.17],0.7501385143133501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,9747,351,1.03 [0.82-1.30],0.8013852366255579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,9866,351,1.04 [0.94-1.16],0.4129881035887747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,9644,346,0.92 [0.73-1.15],0.4562676651721462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,11497,425,0.87 [0.62-1.24],0.446234598333372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,9911,356,0.94 [0.79-1.13],0.5341111985911402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",11348,418,1.00 [0.87-1.14],0.9795963716106092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,9552,341,1.03 [0.89-1.17],0.718516268959134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,11393,413,0.89 [0.78-1.01],0.0774959246677821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,11330,413,1.17 [0.92-1.49],0.1910677906563581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,11376,416,0.99 [0.83-1.19],0.9439467218966168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,9609,341,0.77 [0.45-1.32],0.3361934934929375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,11395,417,0.84 [0.62-1.13],0.2465662936576428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,11200,414,1.26 [0.97-1.65],0.0840036565856649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,11520,426,1.04 [0.95-1.13],0.405642351409531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,9644,346,0.99 [0.81-1.20],0.8805329254722166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,9693,343,1.08 [0.69-1.69],0.7435656304600278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,11410,418,1.41 [1.10-1.81],0.0067662282978628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,11410,418,0.92 [0.77-1.10],0.3364592186692895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,11410,418,0.96 [0.84-1.11],0.5949338458169006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,11410,418,1.33 [1.02-1.72],0.0330622246351896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,9902,356,1.31 [1.08-1.61],0.0075784327381708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,11369,412,0.97 [0.73-1.30],0.8551563230836483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,11123,409,0.90 [0.74-1.08],0.2613393364833355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,11557,426,0.91 [0.80-1.04],0.1593561820682245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,9644,346,1.02 [0.80-1.29],0.8959978520617238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,9644,346,0.62 [0.43-0.90],0.0124249430784844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,9552,341,0.97 [0.79-1.21],0.8103985517827079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,11410,418,1.07 [0.99-1.15],0.1067212381264005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,11511,427,0.86 [0.58-1.29],0.4693930449533308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,9644,346,1.14 [0.85-1.52],0.3872177155597452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",11311,412,1.06 [0.97-1.16],0.2143383771811546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,11378,417,1.06 [0.94-1.19],0.3768253760790944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,11145,412,0.90 [0.69-1.17],0.4152201750025691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,11164,413,1.13 [0.96-1.34],0.1367046172644797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,11557,426,0.95 [0.76-1.19],0.6472923262030027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,9874,353,0.93 [0.66-1.32],0.6874271138982438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,11200,414,1.07 [0.89-1.28],0.4796035888871334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,9909,351,1.01 [0.70-1.46],0.9451979287923592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,11387,413,1.01 [0.83-1.22],0.9275025449530762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,9898,356,1.03 [0.93-1.15],0.5383933792939376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,9864,357,1.07 [0.95-1.20],0.2736566726941027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,11451,416,0.92 [0.76-1.12],0.3982707252283939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,9574,343,1.03 [0.87-1.23],0.7260197790920075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",9610,345,1.05 [0.92-1.19],0.475073267550725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,11200,414,1.01 [0.87-1.18],0.8892177267632619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,11354,418,1.01 [0.91-1.13],0.8243893671940477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNST,Consortin,11410,413,1.05 [0.97-1.14],0.2002594087247373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,9574,343,0.91 [0.66-1.25],0.5615563747852295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,11545,425,1.01 [0.72-1.41],0.9569037250368452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,11511,427,0.93 [0.76-1.13],0.456651252046412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,11395,417,1.03 [0.77-1.38],0.8524532568570988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,11395,417,1.19 [0.81-1.74],0.3738328488970233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,11447,424,0.88 [0.69-1.13],0.3116516578421533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,11410,418,1.17 [0.96-1.43],0.1276849055268243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,9644,346,0.99 [0.90-1.09],0.8589093552696319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,9898,356,0.97 [0.78-1.21],0.80155625889954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,9911,356,0.84 [0.57-1.25],0.3978263014341671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,11438,422,0.73 [0.49-1.07],0.107291172305547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,11545,425,1.08 [0.75-1.57],0.6716202447987661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,9866,351,1.14 [0.95-1.37],0.1639544442373149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,9644,346,1.07 [0.95-1.20],0.2758339266645675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,9624,345,1.04 [0.91-1.19],0.5324458458558825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,9911,356,0.79 [0.50-1.23],0.2870792743908954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,11410,413,0.95 [0.76-1.20],0.6868387389253726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,9728,350,0.94 [0.78-1.14],0.5538840523055437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,9673,340,1.05 [0.80-1.38],0.7064050987910893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,11545,425,0.85 [0.65-1.12],0.2561402094742571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,11410,418,1.09 [0.89-1.33],0.3897775844222454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,9747,351,1.13 [0.92-1.38],0.2503774877906636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,11384,418,0.91 [0.64-1.30],0.6102411854236311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,9624,345,1.08 [0.91-1.27],0.3720480924797313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,9864,357,1.16 [0.90-1.49],0.2453306157007287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,11293,412,0.97 [0.74-1.27],0.8402191095148912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,11073,412,1.04 [0.94-1.15],0.474423760116519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',9580,341,1.13 [0.89-1.44],0.329478130139205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,11164,413,0.84 [0.68-1.04],0.106846839625161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",9624,345,1.05 [0.84-1.33],0.6579348453684866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,11186,416,1.07 [0.97-1.17],0.1590479106755631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,9574,343,0.83 [0.62-1.11],0.2028441374033188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",11354,418,1.00 [0.88-1.13],0.9728354448959662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,9898,356,1.27 [0.95-1.71],0.1113835604779875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,11545,425,1.06 [0.93-1.21],0.3485527167109166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,11483,425,1.00 [0.88-1.14],0.9966559164902432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,9494,335,1.12 [0.88-1.43],0.3694529554212408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,11545,425,1.05 [0.91-1.20],0.5004302581374409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,9893,350,1.16 [0.74-1.83],0.5130479454357647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,11417,423,0.94 [0.76-1.17],0.6059160839491902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,9552,341,1.22 [0.91-1.64],0.181527874979869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,11474,425,0.61 [0.48-0.78],8.000578475643787e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",9609,341,0.86 [0.58-1.27],0.4439115978825845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,11520,426,1.03 [0.91-1.17],0.6031590187284657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,9895,356,0.88 [0.68-1.15],0.3497156232561713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,9580,341,0.75 [0.56-1.01],0.0586331552157451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,11487,426,0.95 [0.77-1.17],0.6563426446940838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,11429,424,1.02 [0.90-1.15],0.7882081457764951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,9898,356,0.81 [0.53-1.22],0.3113722104398152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,9871,355,1.01 [0.76-1.36],0.9217806417809372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,11451,416,1.20 [0.99-1.45],0.0567793228834432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,11123,409,1.06 [0.96-1.17],0.2687717840993776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,11311,412,1.05 [0.94-1.18],0.3887890985438011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,9552,341,1.06 [0.87-1.28],0.5748216446619315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,9552,341,1.29 [0.88-1.88],0.1895751332487811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,11241,413,0.89 [0.71-1.11],0.3056075637584078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,9673,340,0.94 [0.71-1.26],0.684770770032706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,11430,420,1.03 [0.87-1.21],0.746035045541935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,11105,408,0.93 [0.84-1.03],0.1544585027234206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,11384,418,0.91 [0.66-1.25],0.549272827085997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,11200,414,0.82 [0.70-0.96],0.0153044514994093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,11447,423,0.54 [0.34-0.84],0.0065871183212341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,11330,413,0.96 [0.75-1.23],0.7480443764899258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,11511,427,1.07 [0.91-1.26],0.4212826923428374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,9808,350,0.89 [0.61-1.30],0.5422226948215124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,11407,420,1.03 [0.95-1.12],0.4510574944589727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,11447,423,0.93 [0.66-1.32],0.6852180019050955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,11075,408,1.06 [0.92-1.21],0.4231351910023996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,11545,425,1.01 [0.76-1.33],0.956472579702283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,11330,413,0.97 [0.82-1.16],0.7561367923508753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,9644,346,1.10 [0.91-1.33],0.3077251983268845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,11200,414,1.03 [0.96-1.12],0.413567264067834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,9898,356,1.10 [0.95-1.27],0.2160799805116267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,9874,353,0.82 [0.66-1.01],0.0624678904034682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,9874,353,1.04 [0.94-1.16],0.4366847855961915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,9574,343,1.04 [0.91-1.20],0.534239759018488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,9624,345,1.06 [0.95-1.19],0.3190702632387359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,9580,341,1.03 [0.95-1.11],0.529600837713964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,11447,423,0.70 [0.50-0.99],0.0410238163237823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,9907,357,0.96 [0.74-1.24],0.7607630833897775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,9580,341,0.70 [0.51-0.96],0.0263471738123233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,11330,413,1.03 [0.89-1.19],0.6837155346228125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,9609,341,1.04 [0.81-1.33],0.7493736167191436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,11217,413,0.96 [0.80-1.15],0.6706135284724681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,9609,341,0.95 [0.68-1.33],0.7638071585100791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,9907,357,1.12 [0.78-1.61],0.526505229751993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,9609,341,1.01 [0.87-1.19],0.8590779329145367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,9883,356,1.26 [1.01-1.57],0.0439404749549086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,9911,356,0.97 [0.71-1.32],0.8577158241090945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,9574,343,1.01 [0.81-1.26],0.9093106332344604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,9580,341,1.01 [0.91-1.12],0.896498998985051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,8590,311,1.04 [0.93-1.17],0.4877509824512468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,11429,416,0.79 [0.56-1.10],0.1616077754650384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,11176,407,1.06 [0.90-1.24],0.4801353058556711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,11117,407,1.10 [0.91-1.32],0.3368960662460304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,11408,422,1.01 [0.92-1.10],0.874547343550089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,11252,413,0.94 [0.77-1.16],0.577768405337767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,9726,350,1.01 [0.82-1.24],0.956526847174952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,9779,352,0.80 [0.56-1.14],0.2190248332070355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,11200,414,1.10 [1.00-1.21],0.0564645099394189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,9911,356,1.24 [0.86-1.80],0.2543857752232881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,9911,356,0.99 [0.71-1.38],0.9545159759193048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,9574,343,0.75 [0.52-1.06],0.1064389126000085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,11395,417,0.99 [0.85-1.15],0.8848844519778236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,11386,419,1.00 [0.87-1.14],0.9839148103750022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,9874,353,1.06 [0.92-1.23],0.4074907243197788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,11402,422,0.93 [0.78-1.11],0.4171596532230651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,11363,421,1.10 [0.91-1.32],0.3426724800275345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,10676,392,1.05 [0.83-1.33],0.6578220272820597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,9673,340,0.99 [0.82-1.20],0.9098955860031585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,11429,424,0.95 [0.76-1.18],0.6372558391140098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,11170,412,1.02 [0.91-1.14],0.7686990229240902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,11410,413,0.64 [0.44-0.93],0.0203526300205245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,11557,426,0.84 [0.64-1.11],0.2316368095897715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,9010,325,0.61 [0.38-0.96],0.0316796140847918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,11469,426,1.11 [0.89-1.37],0.3543677271411822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,11416,415,0.66 [0.50-0.87],0.0030679101171161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,9644,346,1.03 [0.81-1.32],0.8018662654112761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,9812,350,1.04 [0.90-1.21],0.5993081531890635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,11330,413,0.91 [0.69-1.20],0.5208197103244843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,11410,418,1.06 [0.89-1.27],0.5003898642814694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,11375,421,0.99 [0.90-1.09],0.8715113733199638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,11447,423,0.82 [0.71-0.95],0.0097409083544892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,11520,426,0.94 [0.84-1.06],0.318746533453052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,11217,413,0.80 [0.64-1.00],0.0454633058722823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,11520,426,0.82 [0.69-0.97],0.0244987755370737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,11217,413,0.94 [0.80-1.11],0.4785537285138186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,11524,424,0.91 [0.62-1.33],0.6148610026956165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,11557,426,1.07 [0.88-1.30],0.4684574187635238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,11391,419,1.08 [0.98-1.18],0.103610100967244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,11372,413,1.11 [1.03-1.20],0.005620935045021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,11557,426,1.05 [0.94-1.17],0.4180528949579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,11331,424,0.93 [0.82-1.06],0.2978968171556561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,11447,423,0.80 [0.69-0.93],0.0038502632364702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,9552,341,0.98 [0.85-1.14],0.8249794055229666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,9756,346,1.11 [0.93-1.33],0.2493498048480285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",9580,341,0.91 [0.79-1.05],0.1991645709951165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,9552,341,0.90 [0.77-1.05],0.1618074755197148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,9911,356,0.81 [0.53-1.23],0.3184873145965319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,9673,340,1.05 [0.93-1.19],0.417992673594042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,11511,427,1.04 [0.97-1.13],0.2573580512920168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,11447,423,1.06 [0.89-1.26],0.5007664044214652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,9609,341,1.02 [0.86-1.22],0.8005338675797076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,9609,341,0.93 [0.77-1.12],0.4495152153458255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,11410,418,1.00 [0.93-1.07],0.98697648368672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",11311,412,1.10 [0.97-1.24],0.1414396929615559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,9893,356,1.06 [0.97-1.17],0.20222309680404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,11339,415,1.03 [0.92-1.14],0.6304842306791528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,9609,341,1.03 [0.85-1.26],0.7634959270786892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,11447,423,1.03 [0.94-1.13],0.4716231643568019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",11429,424,0.89 [0.70-1.13],0.3520755889263076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,9644,346,0.94 [0.60-1.49],0.8079399266857776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,9552,341,1.03 [0.87-1.22],0.7147419941731721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,9552,341,1.09 [0.78-1.52],0.6293810591815356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCN,Decorin,11200,414,0.89 [0.58-1.34],0.5660530402465365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,9673,340,1.04 [0.93-1.16],0.4716601836445104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,11511,427,1.06 [0.93-1.21],0.3624902061625217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,11354,418,1.05 [0.96-1.15],0.2860518210442447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,11164,413,1.08 [0.96-1.22],0.1867217089122544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,11410,413,1.01 [0.76-1.33],0.971386925798664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,9574,343,1.00 [0.87-1.15],0.9928128806576376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,9552,341,0.83 [0.72-0.97],0.0200671622504179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,11429,424,0.96 [0.82-1.13],0.6231473443960376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,9580,341,0.90 [0.68-1.19],0.4426608354876153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",11354,418,0.92 [0.76-1.13],0.4313650423059004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,11400,413,0.91 [0.76-1.10],0.3416782203702015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,9883,356,1.07 [0.92-1.25],0.3599668750408763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,9673,340,1.01 [0.88-1.16],0.8993375168786236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,11520,426,1.23 [0.84-1.78],0.286566816413916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,9911,356,0.93 [0.73-1.19],0.56164924578387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,9866,351,1.05 [0.86-1.27],0.6622268800485693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,9644,346,1.05 [0.79-1.39],0.7383762579839508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,9609,341,0.88 [0.55-1.40],0.5884185228844929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,9609,341,0.87 [0.71-1.07],0.1855168083897217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,9644,346,1.17 [0.93-1.49],0.1862759157707918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,11123,409,1.04 [0.90-1.21],0.5748825797186778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",11410,418,1.04 [0.96-1.14],0.3378291286200701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,11185,404,1.01 [0.85-1.21],0.8685082909520594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,9546,339,0.86 [0.65-1.14],0.2903616461853366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,9574,343,0.94 [0.78-1.14],0.5390279357820149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,9574,343,0.89 [0.76-1.04],0.1307002219906276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,9574,343,1.02 [0.85-1.22],0.8265916733597057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,11222,414,1.00 [0.94-1.07],0.9073316055774426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,9580,341,0.91 [0.71-1.15],0.4210455288306579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,9609,341,1.11 [0.93-1.32],0.2552781441117259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,11557,426,1.09 [0.96-1.23],0.1950287906639752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,9574,343,1.02 [0.81-1.29],0.8502556316264795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,9609,341,1.14 [0.94-1.37],0.1809876374184646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,11217,413,1.10 [0.87-1.40],0.4135954700849391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,9580,341,0.70 [0.53-0.92],0.0096812042768286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,9864,357,0.91 [0.70-1.19],0.4846201363021577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,9874,353,1.07 [0.87-1.32],0.5204443067868789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",11369,412,1.06 [0.98-1.15],0.1160785966683787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,9644,346,1.01 [0.79-1.30],0.9134621595142138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,9673,340,0.88 [0.61-1.27],0.4922203161323778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,11520,426,1.03 [0.90-1.19],0.6313781226031783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,11545,425,0.81 [0.60-1.09],0.1708358471938313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,11310,413,0.80 [0.65-0.97],0.027195279032843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,11354,418,1.07 [0.96-1.19],0.234030665291004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,9874,353,1.09 [0.95-1.25],0.2144560792254418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,9883,356,1.08 [0.89-1.31],0.4194271811642337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,11545,425,0.91 [0.79-1.06],0.2180131555034115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,11429,424,0.75 [0.56-1.00],0.0501224428933023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,9624,345,1.04 [0.94-1.15],0.4427253255275244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,9624,345,1.07 [0.87-1.31],0.5050869719782987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,9624,345,0.93 [0.78-1.12],0.4570617317939207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,9552,341,1.07 [0.86-1.33],0.5523629177574672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,11518,425,1.04 [0.94-1.15],0.4584188621830972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,9874,353,1.02 [0.89-1.18],0.7741255976311551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,11354,418,1.00 [0.90-1.10],0.9318465632250272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,9866,351,1.07 [0.92-1.25],0.3643682301444941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,9673,340,1.08 [0.89-1.31],0.449894200198372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,9589,337,1.06 [0.94-1.20],0.3191222297061478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,11200,414,0.98 [0.83-1.14],0.7583729319074838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,9874,353,1.23 [0.97-1.55],0.0889250837364872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,9624,345,1.03 [0.91-1.16],0.6302733206749926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,9866,351,1.05 [0.92-1.19],0.5135012828987362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,11369,418,1.42 [1.02-1.96],0.0365197797598671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,9574,343,0.98 [0.86-1.12],0.7816147928801731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,9866,351,1.00 [0.92-1.09],0.9986839052797364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,9883,356,1.25 [1.05-1.48],0.0121964042052541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,11330,413,1.12 [0.98-1.29],0.0974893702005305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,9874,353,0.99 [0.83-1.18],0.9153714560066996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,11424,423,1.02 [0.86-1.21],0.8252665778363817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,9644,346,0.89 [0.65-1.21],0.4429932870791554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,9574,343,1.09 [1.00-1.18],0.0485501670359497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,9874,353,1.03 [0.95-1.10],0.509242613820742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,11410,413,1.04 [0.97-1.12],0.2370362667025216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,11311,412,1.20 [0.99-1.46],0.066100637285089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,11354,418,0.90 [0.67-1.20],0.4607268838762716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,11410,418,0.93 [0.73-1.20],0.5963933781997659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,11190,404,0.88 [0.64-1.22],0.4573505107740754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,11354,418,0.90 [0.70-1.17],0.4319188218273524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,11320,412,1.11 [0.97-1.27],0.13765701610922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,11545,425,0.78 [0.56-1.08],0.1350773402109243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,11485,426,1.01 [0.88-1.17],0.8390613918390536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,11330,413,1.06 [0.86-1.31],0.5664844441610075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,11354,418,1.04 [0.90-1.21],0.5837936019298053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,11243,413,0.67 [0.51-0.88],0.0042930049288427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,9883,356,0.82 [0.62-1.10],0.1814720404464716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,11395,417,1.33 [0.97-1.84],0.079935416741803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,11478,426,1.01 [0.79-1.29],0.9432186464792702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,11318,418,1.00 [0.84-1.20],0.9960724744964484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,9673,340,1.10 [0.98-1.24],0.102967385973421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,9842,357,1.21 [0.98-1.48],0.0698312348292087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,9644,346,0.90 [0.75-1.09],0.2871268240033491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,11354,418,0.84 [0.58-1.24],0.3869299177567488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,9898,356,1.06 [0.92-1.23],0.4078545792417793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,11200,414,0.83 [0.71-0.96],0.0104997799949445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,9864,357,1.00 [0.79-1.27],0.9839927642105376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,9644,346,1.00 [0.85-1.17],0.963575892766821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,11164,413,0.96 [0.86-1.07],0.4189572404516005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",9866,351,1.02 [0.93-1.13],0.6556700361288397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,9874,353,1.11 [0.89-1.39],0.3464676378152119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,9864,357,0.97 [0.78-1.21],0.7822349023151625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,9644,346,1.02 [0.89-1.15],0.8117010730275509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,9864,357,1.24 [0.99-1.56],0.0569452299293197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,11330,413,1.07 [0.97-1.17],0.1758900798577414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,11500,427,0.75 [0.56-1.00],0.0512208756569986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,11164,413,0.96 [0.75-1.23],0.7446068955224909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",9898,356,0.94 [0.82-1.07],0.3360390691949294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",9624,345,1.02 [0.91-1.13],0.7701322980836925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,9580,341,1.11 [0.94-1.30],0.225795133327089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,9643,340,1.13 [0.85-1.51],0.3933610497614767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,9574,343,1.02 [0.83-1.25],0.8690789879944881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,11511,427,0.79 [0.64-0.97],0.0268138788329222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,11410,418,1.01 [0.92-1.11],0.8772553754458531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,9864,357,0.99 [0.84-1.18],0.9476100015210228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,9580,341,1.00 [0.75-1.33],0.9946826770758386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,9883,356,1.04 [0.91-1.20],0.5551534196403783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,11200,414,1.01 [0.80-1.29],0.9090882797622488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,9624,345,1.07 [0.74-1.54],0.7280450699997071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,9609,341,0.93 [0.72-1.19],0.560130390603538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,9898,356,1.05 [0.95-1.18],0.3447186558021498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,9866,351,0.87 [0.59-1.30],0.5037655416539544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,9747,351,1.27 [0.97-1.67],0.0879487050954827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,11431,415,0.67 [0.50-0.89],0.0055438488986045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,9883,356,0.97 [0.72-1.29],0.8174333843316793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,11373,416,0.85 [0.61-1.20],0.3580728490215417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,11309,412,0.93 [0.67-1.29],0.6732709343250098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,9644,346,1.11 [0.94-1.30],0.2192085086974837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,11370,419,1.02 [0.94-1.10],0.6881715912881783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,11123,409,1.10 [0.88-1.37],0.4086800474271086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,9866,351,1.40 [1.03-1.91],0.0307349022425987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,11545,425,1.66 [0.96-2.86],0.0670838035470609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,11410,418,1.01 [0.87-1.18],0.868055924700325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,9898,356,1.11 [0.97-1.26],0.1292696589726377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,9624,345,0.99 [0.91-1.08],0.7948449986447759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",9874,353,1.10 [0.93-1.30],0.2589988670491025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",9831,347,1.04 [0.95-1.14],0.3483210800024348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,9580,341,1.06 [0.90-1.24],0.4743203455547233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,9624,345,1.21 [0.97-1.50],0.0904145029889583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,11330,413,1.02 [0.87-1.19],0.8155679393758791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,9609,341,1.03 [0.92-1.16],0.5622888211663485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,11410,413,1.02 [0.89-1.17],0.7501378502215663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,11557,426,1.03 [0.94-1.12],0.5326476088807441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,9883,356,1.13 [0.98-1.31],0.0902627521655269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,9580,341,0.86 [0.67-1.12],0.2579298638128045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,11217,413,1.03 [0.78-1.37],0.8350401910519134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,9883,356,1.05 [0.94-1.19],0.3744959073078718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,9574,343,0.93 [0.82-1.06],0.2911757963292744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,9898,356,1.07 [0.79-1.45],0.6533404686136688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,11354,418,0.92 [0.78-1.08],0.3107687207153757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,9580,341,1.05 [0.80-1.38],0.7193650024851479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,11217,413,1.01 [0.84-1.21],0.9225489178882446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,9133,323,0.98 [0.81-1.20],0.8724111234631049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,11545,425,0.91 [0.55-1.51],0.7173006560353676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,11414,423,1.04 [0.94-1.16],0.4370559939815005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,11520,426,1.12 [0.98-1.27],0.092487212125905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,9624,345,1.02 [0.87-1.20],0.8079579731244694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,9864,357,1.11 [0.93-1.31],0.2438669246072414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,9580,341,1.09 [0.75-1.59],0.6447938473470057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,9580,341,1.05 [0.83-1.34],0.6627649177230729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,11545,425,0.86 [0.59-1.24],0.4190955237336894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,11447,423,1.17 [0.95-1.43],0.1491554146354978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,9624,345,0.92 [0.68-1.23],0.5556869775235185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,11075,415,0.98 [0.88-1.09],0.7306747323768337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,9864,357,1.17 [0.98-1.39],0.0792857812083757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,11123,409,1.16 [0.94-1.42],0.1662472661447013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,11200,414,0.78 [0.53-1.15],0.2096310624829977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,11200,414,0.73 [0.54-0.99],0.0421352432080621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,9624,345,0.90 [0.76-1.07],0.2488507294609953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,9609,341,1.22 [0.91-1.65],0.1871140197238447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,9644,346,1.01 [0.86-1.18],0.9489913119908262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,11386,419,1.11 [1.01-1.22],0.0294689726790563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,9864,357,1.13 [0.94-1.37],0.1884784732514038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,11424,423,0.78 [0.60-1.01],0.0640782588790842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,11164,413,0.99 [0.86-1.14],0.8833072653660451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,10989,395,0.85 [0.62-1.18],0.3356523529077865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,9673,340,1.00 [0.69-1.44],0.9975934119858058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,11545,425,0.80 [0.56-1.17],0.2510651843273481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,11311,412,1.11 [0.83-1.48],0.4723382409673646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,11200,414,0.87 [0.74-1.02],0.0796831822680948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,9747,351,1.08 [0.85-1.37],0.5271831002538973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,11410,418,0.94 [0.82-1.06],0.3066848461176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,9624,345,1.02 [0.89-1.17],0.7431733713908418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,11496,426,0.81 [0.60-1.08],0.1477412591453466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,11429,424,1.12 [0.79-1.59],0.5379988582517399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,11342,418,1.06 [0.68-1.65],0.8077770983223436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,11429,424,1.00 [0.70-1.43],0.9912002802560832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,11354,418,1.05 [0.96-1.14],0.2717274465347385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,9644,346,1.13 [1.01-1.28],0.0396204475112798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,9552,341,1.16 [0.84-1.59],0.3623912049462173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,11311,412,1.05 [0.94-1.17],0.3711468483804016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,9747,351,0.94 [0.70-1.28],0.7131662831196862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,9609,341,0.97 [0.77-1.23],0.8044517873191432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,9864,357,1.12 [0.86-1.46],0.3959473349333167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,9673,340,1.04 [0.95-1.13],0.4186640934563058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,11338,417,1.17 [0.84-1.62],0.3539933959415706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,9580,341,0.93 [0.73-1.19],0.5688816026144132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,11545,425,0.88 [0.67-1.16],0.3739971607515772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,11384,418,0.81 [0.63-1.05],0.1100945275210791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,9552,341,1.04 [0.86-1.26],0.6639154482120906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,9609,341,0.92 [0.76-1.10],0.3562183829673747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,9874,353,1.09 [0.97-1.23],0.1564076701185972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,9552,341,1.16 [0.93-1.45],0.1816888641780459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,9609,341,1.04 [0.93-1.16],0.5229751650502696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,9747,351,1.07 [0.79-1.45],0.680842123121749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,9580,341,0.98 [0.81-1.17],0.7971933436303098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,9580,341,1.18 [0.98-1.44],0.0853583671450648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,11520,426,0.90 [0.63-1.28],0.5447174787005576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,9907,357,1.07 [0.74-1.54],0.717691016187544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,9762,342,1.14 [0.86-1.52],0.3616308071125274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,11395,417,1.07 [0.92-1.24],0.4012006462015244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,9909,351,1.00 [0.78-1.28],0.9990312794781836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,9863,348,1.14 [0.77-1.70],0.5095239535396872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,9909,351,1.58 [0.81-3.07],0.1804167469855421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,11430,420,1.12 [0.97-1.29],0.1353519580996918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,11439,425,1.67 [1.22-2.29],0.0014595540320998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,11431,416,0.82 [0.62-1.10],0.1904423918961633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,11439,415,0.88 [0.55-1.42],0.6082054884821437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",11384,418,0.94 [0.85-1.03],0.1767288188618022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",11410,413,1.00 [0.90-1.12],0.9484590788000292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",9898,356,0.98 [0.81-1.18],0.8116758413102356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",11545,425,0.80 [0.67-0.96],0.0186978697890677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,11487,424,1.04 [0.92-1.18],0.5626075642827445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,11184,414,0.89 [0.75-1.05],0.1668834275981832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,11410,418,1.13 [0.97-1.32],0.1138520042454005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,11410,413,1.08 [0.97-1.21],0.1726819420677672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,9866,351,1.07 [0.92-1.23],0.3786837884081248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,9883,356,1.03 [0.96-1.09],0.4385830887337985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,9864,357,1.18 [0.85-1.65],0.3199546445324207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,9624,345,1.10 [0.93-1.30],0.2588188394663113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,9898,356,0.87 [0.60-1.27],0.4792340161123731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,11354,418,1.07 [0.84-1.36],0.6018537365925718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,11400,413,0.85 [0.63-1.16],0.3129832408742027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,9866,351,1.04 [0.92-1.17],0.5584707708686332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,11545,425,1.16 [0.85-1.60],0.3522146596745247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,9644,346,1.10 [0.95-1.26],0.2020135147723996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,11504,424,0.78 [0.58-1.04],0.0944960937299357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,11557,426,1.05 [0.83-1.31],0.6997578466254164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,9911,356,0.70 [0.51-0.96],0.0250919573488891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,9644,346,0.97 [0.81-1.16],0.7204182359332822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",11410,413,0.96 [0.85-1.08],0.468859198192057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,9898,356,0.90 [0.77-1.04],0.1352349912522865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,11410,418,0.86 [0.71-1.03],0.1004010522134684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,9883,356,0.85 [0.56-1.29],0.44320344460115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,11395,417,0.89 [0.74-1.06],0.1955175133035238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,11357,411,1.06 [0.91-1.24],0.44608960841791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,11123,409,1.05 [0.91-1.22],0.5188888596862677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,11415,416,0.92 [0.78-1.10],0.361472501741705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,9893,356,0.95 [0.79-1.13],0.5395579944264576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,11356,413,1.04 [0.83-1.29],0.7445757785302796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,11410,413,0.98 [0.80-1.20],0.812227810153709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,11512,425,1.01 [0.84-1.22],0.8865470706740691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,11217,413,1.08 [0.92-1.28],0.3418015456963345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,11395,417,0.82 [0.70-0.95],0.0095426841291273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,11410,418,1.02 [0.90-1.16],0.769120776800853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,11123,409,0.91 [0.78-1.07],0.2712471973585368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",9580,341,0.97 [0.82-1.15],0.7212516852111862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",9580,341,1.08 [0.90-1.30],0.4160042885669822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,11123,409,0.90 [0.78-1.05],0.1764554696325003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,11123,409,1.15 [0.97-1.36],0.1093733270608973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,11439,415,0.78 [0.62-0.99],0.0389199608075238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,9687,342,1.05 [0.74-1.48],0.7926594834798504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",9883,356,1.06 [0.94-1.20],0.3392984602403502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,9609,341,1.05 [0.84-1.30],0.6871161554332836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,9609,341,0.89 [0.70-1.14],0.3565556469128527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,11447,423,1.14 [1.02-1.27],0.0194678824129052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,11410,418,1.07 [0.94-1.21],0.2958968051472119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,9609,341,0.99 [0.76-1.27],0.9082621137297944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,11500,427,0.98 [0.91-1.05],0.5567934956268269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,11490,425,1.07 [0.90-1.28],0.4318624109526411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,9609,341,1.09 [0.78-1.51],0.6224848409097785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,11217,413,1.09 [0.85-1.40],0.4989549348325151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,9609,341,0.98 [0.75-1.28],0.8990240653570118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,9552,341,1.07 [0.95-1.20],0.2889702836190605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,9532,341,0.98 [0.76-1.28],0.9042921732014172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,11429,424,0.95 [0.73-1.23],0.6803031563336455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,9911,356,1.18 [0.97-1.44],0.1019786092674122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,9874,353,1.08 [0.82-1.42],0.5953569679273714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,11429,424,0.71 [0.48-1.05],0.0883474793065825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,9673,340,1.02 [0.84-1.25],0.8227886717056689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,9907,357,0.99 [0.84-1.17],0.8957146610403068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,11164,413,0.94 [0.80-1.09],0.4140688408361446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",9574,343,1.00 [0.88-1.14],0.9886502268042576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,9580,341,1.01 [0.80-1.27],0.9292058006939116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,11164,413,1.07 [0.95-1.21],0.2580235418747126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,11385,422,1.05 [0.94-1.17],0.4004135417167666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,9883,356,1.03 [0.93-1.14],0.550032718383954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,11469,424,1.04 [0.97-1.12],0.2692349399253836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,11330,413,1.05 [0.86-1.29],0.6096008004675427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,11330,413,1.03 [0.94-1.13],0.477240633579951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,11145,412,1.24 [1.06-1.45],0.0059946294951756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,9866,351,1.10 [0.93-1.30],0.262549379094738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,11123,409,1.06 [0.98-1.14],0.1515287412750203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,11330,413,0.94 [0.69-1.27],0.6860744999874695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,11340,417,0.97 [0.65-1.46],0.8923262128475482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,11123,409,0.99 [0.74-1.34],0.9687670388042904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,11557,426,0.73 [0.57-0.93],0.0123402392184166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,11429,424,1.00 [0.78-1.28],0.9822502603835468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,11164,413,0.96 [0.84-1.10],0.5706718404747673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,11123,409,0.93 [0.73-1.19],0.5765959104357148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,9909,351,0.98 [0.67-1.43],0.8998831450729351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,9874,353,0.88 [0.71-1.09],0.2445129856056242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,9864,357,1.14 [0.87-1.48],0.3365793382622664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,9609,341,0.99 [0.89-1.09],0.7778474101035288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,11379,423,0.87 [0.63-1.18],0.3667031310681049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,11520,426,0.75 [0.56-1.00],0.0520284039785894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,11393,421,1.02 [0.98-1.06],0.38465222877096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,9532,341,1.04 [0.78-1.38],0.7909629720482897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,11164,413,1.01 [0.80-1.26],0.95455584339891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,9609,341,1.14 [0.93-1.41],0.2052753299698954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,11410,418,1.07 [0.97-1.18],0.2004760685367413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,11123,409,1.06 [0.97-1.15],0.2209305178532952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,9580,341,1.03 [0.89-1.20],0.6544873450757156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,9644,346,1.04 [0.77-1.41],0.7841295638539199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,11296,410,0.96 [0.68-1.33],0.7870226503146387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,9624,345,1.09 [0.86-1.38],0.4568276443423195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FST,Follistatin,11430,420,1.03 [0.86-1.22],0.7705243199904974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,9624,345,0.89 [0.57-1.39],0.6110475032422953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,11371,419,0.70 [0.52-0.95],0.0201579879082514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,9852,353,0.89 [0.79-1.01],0.0713325340191068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,11459,422,0.97 [0.87-1.08],0.5786355139207355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,9673,340,0.97 [0.82-1.14],0.6842756448658521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FURIN,Furin,11429,424,1.10 [0.85-1.41],0.4802841887439272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,11102,407,1.14 [0.92-1.41],0.2452786058584723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",9734,351,1.08 [0.92-1.27],0.3463749799318714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,11520,426,0.96 [0.80-1.16],0.674548626786873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",11330,413,0.95 [0.82-1.10],0.4884779627495089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",11511,427,1.02 [0.91-1.15],0.726831744822117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,11217,413,1.10 [0.96-1.26],0.157386829022194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,11378,417,1.03 [0.94-1.13],0.533162531491725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,9644,346,0.81 [0.66-1.01],0.0588722978985156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,9574,343,1.04 [0.82-1.33],0.738808789319604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,9864,357,0.87 [0.70-1.10],0.2483053217182312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,9747,351,1.07 [0.93-1.23],0.3205850742224251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,9574,343,0.94 [0.79-1.11],0.449535160812048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,9552,341,1.45 [0.98-2.16],0.0642829916201103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,9609,341,0.97 [0.76-1.24],0.8141580031801108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,9747,351,0.90 [0.72-1.14],0.3933604034896435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,9624,345,1.11 [0.91-1.34],0.2974544870088029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,9552,341,0.98 [0.83-1.17],0.8572145715980538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,11447,423,0.96 [0.84-1.09],0.5110671186217199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,11354,418,1.03 [0.76-1.41],0.8286522872973315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,11511,427,0.95 [0.68-1.31],0.7481973403746711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,11217,413,1.00 [0.81-1.23],0.96893401559488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,9898,356,0.80 [0.56-1.14],0.2117229187821662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,11354,418,1.03 [0.68-1.57],0.8793146032037844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,9580,341,1.17 [0.89-1.53],0.2572660563332237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,9475,333,1.17 [0.82-1.67],0.3952834466744365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,9883,356,1.26 [0.90-1.77],0.1776069167689716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,9747,351,0.99 [0.81-1.21],0.9350465015229864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,11465,423,0.73 [0.52-1.03],0.0757232191874491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,9580,341,1.08 [0.85-1.37],0.5499382344218647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,9874,353,0.97 [0.89-1.06],0.5220730902733617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,9552,341,1.45 [0.99-2.14],0.0580050307395439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",9624,345,1.00 [0.88-1.14],0.9773917698556416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,9644,346,0.98 [0.81-1.19],0.8424328168266799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,9858,353,0.95 [0.81-1.12],0.5358745594283946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,11217,413,0.90 [0.77-1.04],0.1511900862517891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,11164,413,0.97 [0.81-1.16],0.7081985733676042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,9580,341,0.68 [0.51-0.92],0.0109424395940035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,9909,351,1.16 [0.79-1.72],0.4488147540977866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,9874,353,1.04 [0.95-1.14],0.378047035176608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,11123,409,0.98 [0.92-1.06],0.653087835321271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,9442,330,0.89 [0.71-1.12],0.336322551510535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,9580,341,0.77 [0.59-1.00],0.0505860442182191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",11354,418,0.76 [0.59-0.99],0.0418527810551933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,11545,425,0.91 [0.73-1.13],0.4005304125164717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,11410,413,0.91 [0.71-1.17],0.4612304084273756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,11164,413,0.89 [0.70-1.12],0.3249000076736046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,9898,356,0.98 [0.81-1.20],0.8716669923208472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,11104,408,1.01 [0.83-1.23],0.9353046010478684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,11123,409,1.09 [0.95-1.24],0.2249148267418005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,11123,409,0.99 [0.92-1.06],0.7103781516272463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,11500,427,0.85 [0.61-1.19],0.3481119342816451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,11354,418,0.70 [0.46-1.07],0.0980724421478837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,11289,411,0.83 [0.60-1.15],0.2643053587960441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,9604,341,0.95 [0.80-1.12],0.5254700072474194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,11164,413,0.88 [0.76-1.01],0.0710709944472478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,9898,356,1.08 [0.93-1.24],0.3092135784690214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,9882,356,1.10 [0.90-1.35],0.3290177782113904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,11216,408,0.89 [0.69-1.16],0.3844378844288161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,11373,416,1.06 [0.89-1.25],0.516942953053647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,11330,413,1.58 [1.10-2.26],0.0123659724685999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,11400,413,1.01 [0.96-1.06],0.6502561781164231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,11123,409,0.95 [0.90-1.01],0.1134735706480085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,9673,340,1.15 [0.79-1.67],0.4701178818557774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,11164,413,0.89 [0.74-1.07],0.2150352279264595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,11410,413,1.07 [0.96-1.20],0.206163266071344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,9883,356,1.29 [1.00-1.68],0.0521615118819893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,9883,356,1.14 [1.00-1.29],0.0502713171547324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,9673,340,0.98 [0.70-1.36],0.8930802474261834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,9552,341,1.08 [0.88-1.33],0.457606562701536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,9624,345,0.98 [0.78-1.23],0.8522468456108004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,9874,353,0.87 [0.61-1.25],0.4563720186880395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,9866,351,1.10 [0.99-1.22],0.0827358076483089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,9609,341,1.00 [0.80-1.23],0.9646082213788586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,9609,341,1.05 [0.95-1.17],0.3396736725620403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,9552,341,1.07 [0.92-1.26],0.3805979763970154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,10950,405,0.94 [0.68-1.29],0.700956361153811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,9656,340,0.77 [0.59-1.01],0.0601993660899549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,11330,413,0.94 [0.77-1.14],0.5217384623174465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,9609,341,1.04 [0.79-1.39],0.7626581205081895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,11200,414,1.01 [0.87-1.18],0.8529952124974851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,11368,419,1.06 [0.83-1.36],0.626821587823482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,9574,343,1.01 [0.76-1.35],0.949920025956294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,11334,412,0.99 [0.85-1.15],0.8804035982676706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",9673,340,1.06 [0.94-1.19],0.3293886252008789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,11164,413,0.87 [0.70-1.07],0.1886930710803601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,9864,357,0.90 [0.75-1.08],0.2723325594845369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,9668,351,0.89 [0.66-1.22],0.4705399969454249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,9898,356,1.06 [0.92-1.21],0.4257014897591976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,11557,426,1.07 [0.89-1.28],0.4777095251243136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,9673,340,1.09 [0.93-1.28],0.2726868789527466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,9883,356,0.96 [0.85-1.08],0.4999807805440289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,11123,409,1.04 [0.91-1.19],0.58647873416661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,9644,346,0.96 [0.78-1.18],0.6934247802192541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,11395,417,0.89 [0.76-1.05],0.1619911336144147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,9624,345,1.05 [0.77-1.42],0.7687826661583658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,9673,340,1.39 [1.06-1.83],0.0173876074462528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,9883,356,1.05 [0.92-1.19],0.4686794272351144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,11520,426,0.93 [0.63-1.37],0.7129306395543864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,11410,418,1.05 [0.96-1.14],0.2969887605940132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,9866,351,1.13 [0.92-1.40],0.2381492300810199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",9911,356,0.89 [0.70-1.13],0.3299036171783962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,11355,410,1.14 [0.88-1.49],0.3259634649351863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,9580,341,0.94 [0.81-1.09],0.4084487933377886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,11056,411,1.26 [1.15-1.38],2.466370545992822e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,9673,340,1.10 [0.82-1.47],0.5233154177303856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,11378,417,1.02 [0.92-1.12],0.7138875266919591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,11354,418,1.09 [1.02-1.16],0.0105539970293639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,11511,427,0.80 [0.59-1.07],0.1341800849926034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,11330,413,1.03 [0.88-1.21],0.6798583897602273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,9864,357,1.01 [0.84-1.21],0.9360922686833714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,9866,351,1.11 [0.90-1.37],0.3276194416690389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,9907,357,1.09 [0.89-1.33],0.4246551388787527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,9866,351,1.00 [0.87-1.15],0.9808613427520834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,11164,413,1.09 [0.82-1.45],0.5384407405639802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,11109,409,0.83 [0.60-1.13],0.2375564598946311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,9574,343,1.01 [0.84-1.21],0.9434832029047376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,9883,356,1.08 [0.81-1.44],0.6188682374751309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,9866,351,0.99 [0.85-1.16],0.9150785468942269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,11200,414,0.96 [0.83-1.11],0.5794523057353911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,9864,357,0.94 [0.78-1.13],0.4828003723294912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,11410,413,1.03 [0.96-1.10],0.3825291918322629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,9898,356,1.05 [0.90-1.23],0.5342454276621817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",9883,356,1.17 [0.92-1.48],0.2035522638663789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",9574,343,0.99 [0.81-1.21],0.933633775822574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,11200,414,1.06 [0.90-1.25],0.5005933434869138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,11338,416,0.85 [0.59-1.23],0.3938858078967048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,9624,345,1.18 [0.96-1.44],0.1119546568216879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",11354,418,0.96 [0.83-1.10],0.5405624280902144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,9493,339,1.06 [0.94-1.19],0.3748045761456018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,11123,409,1.04 [0.94-1.15],0.4623874138521608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,9860,352,1.37 [0.81-2.34],0.2424552828224603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",9858,355,1.33 [0.84-2.09],0.2223673440045383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,11393,413,1.01 [0.91-1.12],0.8664845423219698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,11123,409,0.98 [0.87-1.09],0.6853186850948019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,9580,341,0.91 [0.78-1.06],0.2391551958457958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,11090,410,1.11 [0.98-1.25],0.092266412250859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,9874,353,1.03 [0.99-1.08],0.1200280810538379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,9747,351,0.92 [0.78-1.09],0.3504142438725637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,9644,346,1.09 [0.96-1.23],0.184322295041087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,11338,415,0.97 [0.74-1.29],0.8492524117463645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,9747,351,1.07 [0.95-1.21],0.2381198766571494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,9580,341,0.92 [0.69-1.22],0.5548970882543711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,11444,421,0.87 [0.75-1.00],0.0497999116948497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",11200,414,1.06 [0.96-1.16],0.2443367883408901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,11557,426,0.82 [0.63-1.06],0.1372204290573011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,11410,418,0.95 [0.83-1.09],0.4898674449000434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,11200,414,0.97 [0.87-1.09],0.6328494135446983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,9552,341,1.04 [0.85-1.26],0.7156193496760295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",9580,341,0.96 [0.81-1.15],0.6879072455663455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",11484,426,0.95 [0.84-1.07],0.4069630441445205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,11511,427,0.93 [0.87-1.00],0.0440774494673265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",11395,417,1.06 [0.95-1.18],0.3066027182981016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,11495,426,1.03 [0.89-1.19],0.6756683907638934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,11395,417,0.84 [0.65-1.10],0.2039617517491916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,11484,426,0.98 [0.88-1.10],0.761525513111062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,11511,427,0.94 [0.82-1.08],0.3716393800597252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,9898,356,0.95 [0.87-1.04],0.2896546270121563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,9580,341,1.13 [0.97-1.32],0.1257496823879626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,11557,426,1.06 [0.91-1.24],0.4292617539298691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,9609,341,0.97 [0.82-1.15],0.7446856684040183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,9574,343,1.06 [0.90-1.24],0.48653302808962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,9866,351,0.97 [0.77-1.22],0.7894154632091518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,11497,427,0.93 [0.85-1.02],0.1223049853148536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,9874,353,1.15 [0.99-1.34],0.0598221666963558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,11200,414,0.85 [0.71-1.02],0.0737444346789145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,9673,340,1.20 [0.82-1.76],0.3493436076441513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,9874,353,1.08 [0.85-1.36],0.5421044778600924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,9898,356,1.29 [0.88-1.90],0.1953520008471032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,11410,418,1.11 [1.00-1.23],0.0607784608470387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,11557,426,0.84 [0.65-1.08],0.1732061084411718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,9816,351,1.41 [0.95-2.08],0.0852432725929267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,11123,409,1.03 [0.92-1.15],0.6390203782112122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,9874,353,1.04 [0.92-1.18],0.5386474645006067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,9609,341,1.01 [0.86-1.18],0.9266259194557936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,9580,341,0.74 [0.52-1.05],0.0889769534583646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,9856,353,0.84 [0.66-1.08],0.1789173606881164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,9883,356,0.86 [0.67-1.10],0.2381106502169339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,11200,414,0.92 [0.67-1.27],0.6162418976342091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",9883,356,1.13 [0.83-1.55],0.4319034369678137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",11369,417,0.80 [0.63-1.03],0.0829476668359948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",11410,418,0.96 [0.69-1.32],0.7821280887762464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,11511,427,0.93 [0.76-1.15],0.5219385722775833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,9653,339,0.99 [0.83-1.19],0.9363353659576268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",9624,345,1.01 [0.82-1.24],0.934111943776951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",9580,341,0.77 [0.59-1.00],0.0466344066389146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,9530,341,0.89 [0.70-1.13],0.3397221476000948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,11282,411,1.01 [0.84-1.21],0.9491818124638542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,11164,413,1.08 [0.91-1.28],0.3958735018934377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,9644,346,0.95 [0.81-1.11],0.5174753246061079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,11278,411,0.83 [0.69-1.00],0.0450666313239772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,11156,412,1.07 [0.96-1.20],0.2042504549501521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,9883,356,1.12 [0.92-1.35],0.2555502657487278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,11557,426,1.04 [0.93-1.17],0.4778799383195101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,11123,409,1.18 [0.94-1.49],0.1573400803554447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,9794,351,1.02 [0.92-1.14],0.7058680491452556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,9732,349,0.97 [0.87-1.08],0.5713888226140663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,9624,345,1.05 [0.75-1.46],0.7718349425445872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,9863,348,0.85 [0.61-1.16],0.3035301325799734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,9624,345,1.05 [0.94-1.17],0.3984092265549612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,11354,418,0.93 [0.74-1.17],0.522182118704596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,11511,427,1.05 [0.81-1.36],0.6865370530856163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,9609,341,1.07 [0.80-1.43],0.6309459419048209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,9624,345,0.98 [0.88-1.09],0.7015907509376046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,11410,418,0.98 [0.79-1.22],0.8613740462591932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,9874,353,0.86 [0.73-1.01],0.0686607441997764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,9580,341,1.08 [0.87-1.34],0.5049858979609767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,9624,345,1.00 [0.81-1.24],0.9760579956869836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,11120,412,0.88 [0.75-1.02],0.089297889784771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,11424,423,1.05 [0.94-1.19],0.3848771172400076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,9864,357,1.36 [1.09-1.69],0.0059534729977305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,11221,409,1.07 [0.94-1.21],0.2930863205066513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,11511,427,0.93 [0.74-1.15],0.4917948562832815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,11330,411,0.68 [0.46-0.99],0.0418370910978042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,9574,343,0.89 [0.76-1.04],0.1468188018404571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,9574,343,1.02 [0.80-1.29],0.8926023122115072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",11429,424,1.05 [0.92-1.21],0.4439537619881945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,11347,412,0.78 [0.53-1.15],0.2029830824714216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,11545,425,0.99 [0.67-1.47],0.9707787047913798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,11217,413,1.04 [0.94-1.16],0.4499543439674469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,11357,413,0.69 [0.50-0.94],0.0186836958268726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,11545,425,0.97 [0.74-1.27],0.8229622198028633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,11545,425,1.20 [0.87-1.67],0.2680967631786123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,11410,418,1.08 [0.92-1.28],0.3547193894347176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,11410,413,0.93 [0.77-1.13],0.4560770258903228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,11354,418,0.92 [0.57-1.46],0.7094220305356352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,9747,351,1.05 [0.84-1.32],0.6454934001724295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,11164,413,0.95 [0.79-1.15],0.5867800749834939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",9624,345,0.85 [0.72-1.00],0.0514783886804831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,11557,426,1.52 [0.58-3.99],0.3935586198389816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,11511,427,0.95 [0.79-1.13],0.5492523535892679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,9651,341,0.80 [0.61-1.06],0.1258684192296643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,9747,351,0.88 [0.71-1.08],0.2190455497312776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,9747,351,1.29 [1.01-1.66],0.040225443374414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,9866,351,1.02 [0.69-1.51],0.9117992802620316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,11217,413,0.93 [0.86-1.00],0.0419353469788254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,11447,423,0.74 [0.48-1.14],0.1727414166226892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,11330,413,0.94 [0.79-1.11],0.4418376678834733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,11164,413,0.84 [0.68-1.03],0.0975621144365214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,9574,343,0.95 [0.79-1.14],0.5537963592708304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,11410,418,1.03 [0.81-1.31],0.7980784853441846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,9580,341,0.77 [0.55-1.09],0.1407672834757839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,9644,346,1.10 [0.88-1.37],0.3963171378007738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,9883,356,1.12 [0.95-1.31],0.1854398206753879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,9574,343,1.09 [0.89-1.33],0.4185196727422625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,9911,356,1.23 [0.84-1.80],0.2870356305445893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,11354,418,0.96 [0.63-1.46],0.8527985689258918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,9580,341,1.08 [0.88-1.33],0.4655165562250674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,11395,417,0.84 [0.58-1.21],0.3519800068023108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,11528,425,0.98 [0.92-1.05],0.5837855306756765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,11526,425,0.91 [0.79-1.05],0.2102276592991061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,11451,416,0.98 [0.73-1.32],0.893753055851386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,11262,415,0.94 [0.74-1.18],0.5693917669260677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,11364,412,0.77 [0.56-1.06],0.1119085443910774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,11545,425,0.75 [0.55-1.03],0.0748021513683401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,11410,413,0.73 [0.55-0.98],0.0333272912809922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,9609,341,0.96 [0.83-1.12],0.6359490923371995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,9580,341,0.99 [0.83-1.18],0.8994818684552748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,9897,351,0.77 [0.48-1.24],0.2825898421058238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,9552,341,1.04 [0.94-1.16],0.4461073697081532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,9624,345,1.07 [0.83-1.37],0.6139860632907016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,11354,418,1.05 [0.82-1.35],0.701073516001697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,11410,413,1.04 [0.78-1.39],0.7916172800538518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,9898,356,0.88 [0.78-1.00],0.0443108009759925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,11410,418,1.04 [0.94-1.14],0.4424244808798409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,11123,409,1.01 [0.91-1.11],0.9186615692187382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,11217,413,0.84 [0.75-0.95],0.0064183818172309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,11217,413,1.10 [0.95-1.26],0.2073797372286901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,11447,423,0.76 [0.56-1.03],0.0791435465182821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,11217,413,0.99 [0.86-1.14],0.9332156458969983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,11354,418,0.92 [0.82-1.04],0.1984899431478078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,11557,426,0.86 [0.74-1.01],0.0716053879919402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,11217,413,0.85 [0.67-1.07],0.1625997872168619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,9609,341,1.02 [0.80-1.30],0.8929257129813446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,11217,413,0.85 [0.69-1.05],0.1301279815780633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,11244,416,0.86 [0.60-1.22],0.4006795550386732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,9574,343,1.00 [0.70-1.42],0.9891543833476012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,11410,418,0.93 [0.71-1.21],0.5857104749384685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,11217,413,1.05 [0.81-1.37],0.7020389700462193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,11557,426,0.96 [0.79-1.18],0.721188974337208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,11188,412,0.87 [0.70-1.08],0.2207583894162619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,11217,413,0.90 [0.78-1.03],0.1122345001042068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,11217,413,1.04 [0.80-1.36],0.7595502332738316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,11217,413,0.91 [0.80-1.03],0.1493946926811842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,11395,417,1.09 [0.90-1.33],0.3619256248460126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,11267,412,0.95 [0.80-1.12],0.5188038571454725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,11342,418,0.79 [0.65-0.96],0.0179028770650789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,11451,416,0.62 [0.45-0.84],0.0019781501907588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,11557,426,0.86 [0.67-1.12],0.2661370438572109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,11258,410,1.01 [0.96-1.06],0.6996551306242982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,11132,404,0.90 [0.79-1.02],0.0951749461252121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,11217,413,1.11 [0.97-1.27],0.1354505050800685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,11162,413,0.91 [0.78-1.07],0.2621263093233094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,11373,416,0.91 [0.62-1.34],0.6257370736280079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,11364,418,0.78 [0.50-1.21],0.2645858713466732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,11395,417,0.95 [0.78-1.15],0.5794506992296375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,11504,424,0.99 [0.83-1.18],0.9057897106076286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,11217,413,0.94 [0.74-1.18],0.5747096107848181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,11368,421,0.73 [0.61-0.88],0.0006908698632343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,11217,413,0.93 [0.70-1.23],0.6043411017644627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,11217,413,0.96 [0.79-1.16],0.6523792482682313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,11217,413,1.18 [1.00-1.40],0.0558785608620788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,9609,341,0.99 [0.77-1.26],0.9085309353712928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,9609,341,0.94 [0.76-1.16],0.5576327459934052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,9864,357,0.87 [0.74-1.01],0.0724301036003399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,11217,413,1.01 [0.82-1.23],0.9616063009520214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,11217,413,0.92 [0.76-1.12],0.411019810759566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,9516,340,1.01 [0.74-1.38],0.9505959467099944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,11342,417,0.89 [0.71-1.12],0.3338098792613921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,11217,413,1.07 [0.85-1.35],0.560024690878505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,9864,357,1.11 [0.85-1.45],0.4393308136086323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,9552,341,1.12 [0.94-1.35],0.2101310537604208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,9609,341,0.91 [0.75-1.12],0.3951898351838463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,9579,340,1.00 [0.76-1.31],0.9892333677590668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,11410,418,1.07 [0.87-1.31],0.5313153404839771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,11217,413,0.82 [0.66-1.02],0.07997959602049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,11145,412,0.79 [0.62-1.01],0.0613741812556263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,9609,341,1.00 [0.83-1.20],0.9837021428795424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,9585,340,0.97 [0.83-1.14],0.7300456179802304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,11217,413,0.75 [0.56-0.99],0.043709815658528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,11217,413,0.99 [0.90-1.09],0.8064582902671219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,11410,418,0.97 [0.76-1.24],0.8007582225205756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,11217,413,1.00 [0.94-1.06],0.92722203259058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,11410,418,0.86 [0.73-1.01],0.0672251143878044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,11354,418,0.99 [0.87-1.12],0.8330661597564623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,11338,412,0.83 [0.65-1.07],0.1566360305852884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,11410,413,0.71 [0.42-1.18],0.1858567017313888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,11410,418,1.09 [0.96-1.25],0.1898908777701102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,11395,417,1.07 [0.91-1.27],0.423554978558348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,9747,351,1.21 [1.02-1.43],0.0263027595675309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,11144,413,0.97 [0.84-1.13],0.7397314571418654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,9864,357,1.20 [0.98-1.46],0.0804755643923472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,11330,413,1.08 [0.94-1.25],0.2742113320348129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,9874,353,1.04 [0.87-1.25],0.6722494297838715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,9574,343,1.02 [0.72-1.45],0.8972377300476274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,11145,412,1.22 [1.04-1.43],0.0159219739497327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,9673,340,0.83 [0.67-1.03],0.0966569947416063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,11395,417,0.94 [0.76-1.17],0.5916756498763018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,11354,418,0.98 [0.84-1.15],0.7918223341297455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",9624,345,1.05 [0.88-1.25],0.6124873366152812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",9883,356,0.91 [0.70-1.19],0.5062109180401243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",11354,418,1.03 [0.94-1.12],0.5758870770931689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,9874,353,1.01 [0.90-1.14],0.8210050553257481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,9864,357,1.14 [0.94-1.38],0.1881122771575615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,9866,351,1.05 [0.95-1.16],0.3087351195154407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,9609,341,0.67 [0.35-1.29],0.232510850871468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,11309,412,1.02 [0.93-1.13],0.6560573294677349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,11354,418,0.96 [0.82-1.12],0.584853823136017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",11200,414,1.07 [0.98-1.18],0.1485817437087126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,11217,413,1.07 [0.95-1.21],0.2612134941774232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,11410,418,1.03 [0.95-1.11],0.5347746805486524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,10983,406,0.96 [0.76-1.22],0.7442046598361038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,11410,418,0.91 [0.73-1.13],0.3825490802051321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,9911,356,0.88 [0.70-1.12],0.309587404349027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,9787,346,1.02 [0.92-1.13],0.719763477975568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,11410,418,1.42 [1.11-1.82],0.0057170355057698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,9673,340,1.56 [1.15-2.11],0.0041707450206832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,11395,417,0.78 [0.55-1.11],0.1711832497380146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,11410,418,1.14 [0.97-1.33],0.110363907020154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,9609,341,1.06 [0.83-1.35],0.6617263787925839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,11395,417,0.98 [0.74-1.28],0.8613471934586692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,11511,427,1.58 [0.93-2.67],0.0910727784097034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,9747,351,1.17 [0.97-1.41],0.1047068978486986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,11397,415,1.21 [0.81-1.81],0.3434161555361039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,11123,409,1.23 [0.98-1.53],0.0690231812853754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,11200,414,1.04 [0.96-1.12],0.3651824631496961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,11347,420,0.97 [0.71-1.32],0.8434786482327054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,11429,424,1.07 [0.86-1.33],0.5294918784100238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,11217,413,0.76 [0.56-1.01],0.0620262654406442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,11511,427,1.01 [0.83-1.21],0.9475033683763182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,9911,356,0.83 [0.62-1.10],0.1894207237351478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,9909,351,1.26 [0.74-2.12],0.3941124821263717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,11451,416,0.77 [0.62-0.96],0.0194779828395724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,9909,351,1.10 [0.73-1.66],0.6474617338055879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,9864,357,1.10 [0.88-1.38],0.3989478227834689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,11410,418,0.97 [0.84-1.12],0.699779165445269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,9580,341,1.01 [0.86-1.17],0.9305369623132927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",9624,345,1.01 [0.87-1.17],0.9276145190928132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",9574,343,0.87 [0.68-1.10],0.2487236030802597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",11164,413,1.07 [0.89-1.27],0.4852457008552436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,9552,341,0.93 [0.74-1.17],0.5572574573087516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,11520,426,0.85 [0.60-1.22],0.3843032973686276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,9673,340,1.22 [1.00-1.49],0.0515293541486292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,11217,413,1.07 [0.93-1.24],0.3346896384483429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,9552,341,1.08 [0.91-1.28],0.3749997269463813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,9866,351,1.03 [0.92-1.16],0.5926789196287221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,11217,413,0.94 [0.78-1.14],0.5162332235109314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,11354,418,0.92 [0.76-1.12],0.3964283279707494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,9866,351,1.05 [0.95-1.16],0.3210573269745649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,9574,343,0.92 [0.75-1.14],0.4578548773238402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,9644,346,1.00 [0.87-1.15],0.9816247826418296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,11164,413,0.93 [0.78-1.12],0.4589927526085861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,9674,348,1.04 [0.84-1.30],0.6980381587052562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,9609,341,1.02 [0.92-1.14],0.6578704483349498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,11429,424,1.04 [0.75-1.45],0.8020729483056561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,11164,413,0.93 [0.73-1.19],0.5822584159399096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,9552,341,0.91 [0.76-1.09],0.2986237986684241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,9624,345,0.98 [0.84-1.16],0.8357262629566747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,9874,353,0.90 [0.64-1.27],0.5561929833190147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,9747,351,0.92 [0.79-1.07],0.290126390066442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,9747,351,1.03 [0.70-1.51],0.8751599191730656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,9864,357,1.07 [0.91-1.28],0.4093986188114041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,9580,341,0.71 [0.50-1.02],0.0613803937856907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,9574,343,1.10 [0.97-1.26],0.1392210769391695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,9580,341,1.06 [0.97-1.15],0.216004587508073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,11354,418,1.03 [0.93-1.14],0.5800190039564499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,9864,357,0.88 [0.79-0.99],0.03978078516157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,11123,409,0.86 [0.77-0.97],0.0141667687327954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,9866,351,0.99 [0.93-1.05],0.6213661481369224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,11123,409,0.97 [0.90-1.04],0.4345931570510646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,9552,341,1.02 [0.89-1.16],0.8162955435853557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,9574,343,1.09 [0.93-1.28],0.309998016509006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,11164,413,0.97 [0.77-1.21],0.7698407720028888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,11439,415,1.01 [0.75-1.36],0.9527865688516818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,11410,413,0.96 [0.76-1.22],0.7647141505950944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,11164,413,1.00 [0.89-1.12],0.9883196469479666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,9574,343,0.96 [0.74-1.24],0.7444336281375137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,9883,356,0.94 [0.78-1.14],0.5355561939308833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,11298,421,0.98 [0.91-1.05],0.5328766699287151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,11392,422,1.06 [0.85-1.32],0.5882200402198161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,11315,421,1.21 [0.91-1.62],0.1889226791189993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,11123,409,1.03 [0.96-1.10],0.4253276300748946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,11129,410,1.11 [0.90-1.36],0.3330079684046887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,11511,427,0.88 [0.73-1.07],0.1992602334134421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,9847,357,1.23 [1.01-1.50],0.0436201779943734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,9911,356,2.38 [2.22-2.55],1.7301319399826719e-133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,11511,427,0.93 [0.80-1.07],0.3110172580265392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,11405,424,0.92 [0.69-1.22],0.5489490691725483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,9450,332,1.09 [0.84-1.43],0.5033049996788197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,11011,411,0.84 [0.65-1.08],0.1814184789688597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,9723,341,0.89 [0.59-1.36],0.5957117591939707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,11557,426,0.91 [0.72-1.15],0.4226596910214124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,9574,343,1.13 [0.97-1.31],0.1227473509841428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,11557,426,0.93 [0.77-1.12],0.4268353287388907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,9609,341,0.89 [0.70-1.14],0.3651327491264928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,9874,353,0.95 [0.76-1.18],0.6423258948942072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",10823,397,1.08 [0.80-1.44],0.6232186807939224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",9580,341,0.80 [0.60-1.07],0.1249600683975397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",11354,418,0.92 [0.82-1.02],0.1083864883169428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",11395,416,1.01 [0.88-1.16],0.8946528154830858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",11164,413,1.12 [0.95-1.32],0.1905588260697362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",9580,341,1.06 [0.81-1.38],0.6780223745785403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",9574,343,0.93 [0.80-1.09],0.3979529998127508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,11389,412,1.05 [0.90-1.23],0.5026488332414086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,11557,426,0.95 [0.79-1.15],0.5980769371998623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,11429,424,0.77 [0.58-1.02],0.0702266802690256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,9898,356,1.05 [0.94-1.18],0.3648312837015816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,9842,356,1.05 [0.84-1.31],0.673527889597644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,11410,413,1.06 [0.93-1.21],0.3621689573041537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,11354,418,0.85 [0.67-1.06],0.1524637212728074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,11384,418,0.82 [0.64-1.04],0.0998972097376538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,11330,413,0.92 [0.85-0.99],0.0368809167562217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,9580,341,0.83 [0.67-1.05],0.119678355298527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,11447,423,1.08 [0.84-1.39],0.5471476827440585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,9624,345,1.08 [0.77-1.50],0.6677750379878945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,9637,347,0.68 [0.44-1.05],0.0812730281753176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,11071,409,1.29 [0.83-2.00],0.2611517806634045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,11536,426,0.90 [0.76-1.06],0.2038472930780818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,9864,357,1.19 [0.95-1.49],0.1344287798257694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,11217,413,1.02 [0.85-1.23],0.846880991357593
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,9864,357,1.14 [0.99-1.33],0.0737490754209217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,11557,426,1.07 [0.96-1.20],0.2189682246888145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,11354,418,1.04 [0.97-1.11],0.2744390741308776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,9609,341,1.03 [0.91-1.16],0.6619370429626255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,11311,412,0.89 [0.67-1.18],0.4106801133539385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,11451,416,0.94 [0.81-1.09],0.4081073842262305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,11520,426,1.05 [0.93-1.18],0.4288787124993308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,9907,357,1.10 [0.68-1.78],0.6863280692865501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,9883,356,1.04 [0.88-1.22],0.6520187286560672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,11074,401,0.87 [0.68-1.11],0.2517183252889904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,9911,356,1.04 [0.84-1.28],0.7124925312563462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,11429,421,0.99 [0.84-1.17],0.9295964659108202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,9883,356,1.03 [0.93-1.13],0.6010445194676717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,9898,356,0.98 [0.84-1.15],0.8179680185523747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,11500,427,0.89 [0.75-1.05],0.1588986356798721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,9318,329,1.16 [1.01-1.35],0.040726095246023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,9574,343,0.95 [0.81-1.11],0.5048443635660069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,9883,356,1.20 [0.86-1.67],0.2841547627723372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,11410,413,0.94 [0.83-1.06],0.3159858526381659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,11410,413,0.89 [0.67-1.19],0.4352617264634792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,9883,356,1.07 [0.89-1.28],0.4874193651100235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,11410,413,0.84 [0.65-1.10],0.2024574301692418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,11432,422,0.98 [0.73-1.31],0.8772081133306344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,9909,351,1.23 [0.90-1.69],0.199547651366206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,11384,418,0.84 [0.71-0.99],0.0345011372158032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,11385,420,1.08 [0.88-1.32],0.4615649136113728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,11520,426,1.05 [0.92-1.21],0.448681416080575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,11391,419,0.77 [0.57-1.03],0.081508719015019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,11447,423,0.93 [0.73-1.18],0.5546782632430598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,11123,409,1.02 [0.92-1.12],0.7500898584887064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,11407,422,1.09 [0.95-1.26],0.2300282071666746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,11164,413,1.04 [0.88-1.24],0.6313362195767784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,11410,418,0.78 [0.54-1.14],0.1986074957403254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,11395,417,0.94 [0.74-1.19],0.6185962578149808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,9911,356,1.03 [0.95-1.11],0.5210941021889177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,9580,341,1.03 [0.83-1.27],0.7868315082862347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,11400,413,1.03 [0.79-1.35],0.83204707169623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,9898,356,1.02 [0.89-1.17],0.7588280933981979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,11545,425,0.98 [0.72-1.34],0.9047763283637986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,11485,424,1.09 [0.85-1.40],0.4907346727720278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,11217,413,0.97 [0.78-1.20],0.7901754826997148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,11545,425,1.03 [0.91-1.17],0.6273126980269972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,9624,345,1.06 [0.89-1.25],0.533868921294038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,9845,350,1.00 [0.86-1.18],0.9593109831544512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,9874,353,1.04 [0.72-1.52],0.8175717922842267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,9883,356,0.99 [0.73-1.34],0.9403782755412026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,9574,343,0.97 [0.81-1.15],0.7049124617434253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",9624,345,1.03 [0.92-1.16],0.5783487345897305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),9688,341,1.00 [0.95-1.06],0.9024518811507308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,11354,418,0.93 [0.75-1.16],0.5240346146981042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,11410,413,0.98 [0.82-1.17],0.8360607814849395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,11028,402,1.09 [0.94-1.26],0.2437452233106411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,9580,341,1.07 [0.92-1.25],0.3954229057629457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,9580,341,0.95 [0.82-1.11],0.5228614724115854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,9644,346,0.94 [0.75-1.18],0.6217120571374924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,9909,351,0.93 [0.62-1.39],0.7090906189782272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,11484,426,1.10 [0.86-1.42],0.4415485957167541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,9577,337,0.84 [0.56-1.27],0.4197826374813705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,11354,418,1.22 [0.88-1.68],0.2249162791739002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,11410,413,0.98 [0.77-1.26],0.8995139718921418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,9644,346,1.08 [0.82-1.42],0.5987108674055138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,9644,346,1.06 [0.94-1.20],0.3393010842360935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,11520,426,1.07 [0.92-1.24],0.3615517803001288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,11354,418,1.00 [0.79-1.25],0.9695759373176353
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,9866,351,0.94 [0.74-1.19],0.6145530127165029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,9644,346,1.00 [0.80-1.25],0.9848278400275474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,9898,356,1.19 [0.98-1.45],0.0773071558769328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,9864,357,1.18 [0.97-1.43],0.1037562074716413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,11217,413,1.03 [0.83-1.29],0.7667554376362467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,9644,346,1.04 [0.81-1.32],0.7794039077317698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,9883,356,1.05 [0.71-1.57],0.802741620995422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,11123,409,0.99 [0.84-1.17],0.9275546687149256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,9747,351,0.95 [0.83-1.09],0.4674586066902056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,11410,418,0.96 [0.78-1.20],0.7397084944720898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,11410,418,1.13 [0.90-1.41],0.2918988170163102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,11511,427,0.96 [0.83-1.11],0.5519781607953566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,9864,357,0.88 [0.64-1.21],0.4214965119526738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,11545,425,1.02 [0.76-1.36],0.899877640599399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,11123,409,0.81 [0.68-0.97],0.0240319939056069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,11322,417,0.68 [0.49-0.94],0.0201731660525358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,11217,413,0.73 [0.57-0.93],0.012270782007739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,9864,357,0.88 [0.69-1.12],0.3067277204307158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,11274,409,1.06 [0.94-1.20],0.3302995249837419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,11331,420,0.72 [0.56-0.92],0.0096888416916806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,11410,418,0.88 [0.70-1.10],0.2484126991676316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,11292,416,1.05 [0.78-1.42],0.7332957632009176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,11330,413,0.91 [0.72-1.16],0.4472061620709818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,11123,409,0.99 [0.84-1.17],0.9239516095642664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,11354,418,1.06 [0.96-1.17],0.2848690927835774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,11164,413,0.96 [0.82-1.11],0.5792918500660862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,11343,420,0.86 [0.67-1.11],0.2565996149000141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,11123,409,1.15 [0.98-1.35],0.0960550404601447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,9574,343,0.95 [0.86-1.06],0.3729928575684746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,9644,346,1.06 [0.96-1.17],0.2371172779850031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,9909,351,1.43 [0.84-2.43],0.1854121342763903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,9552,341,1.02 [0.77-1.35],0.8983527659824941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,9673,340,1.13 [0.98-1.30],0.0878522608926772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,9624,345,0.93 [0.70-1.25],0.6432309965650185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,11296,411,1.01 [0.85-1.21],0.8668639037932958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,11123,409,1.04 [0.83-1.30],0.726799029789707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,9644,346,0.94 [0.75-1.18],0.5881404655701418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,9747,351,1.07 [0.94-1.22],0.3360231762232631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,11123,409,1.08 [0.90-1.30],0.3859089267910569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,9898,356,0.63 [0.46-0.86],0.0035120280860639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,9864,357,1.04 [0.87-1.24],0.6553743135715049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",9624,345,1.07 [0.71-1.62],0.7352107369541397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,9898,356,0.88 [0.74-1.05],0.1631965750417954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",9552,341,0.89 [0.72-1.09],0.2621622352834951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,11447,423,1.03 [0.96-1.10],0.4562684947757839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,11429,424,0.88 [0.64-1.21],0.4223515190475777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,9580,341,0.90 [0.76-1.07],0.2252148503995714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,9574,343,0.93 [0.68-1.29],0.6814237022725618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,9580,341,1.04 [0.89-1.22],0.6033776830970574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,9874,353,1.10 [0.90-1.35],0.3622737455117831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,9866,351,1.04 [0.89-1.22],0.5905979624574456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,11410,418,1.06 [0.97-1.16],0.1901442271744639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,11123,409,1.08 [0.99-1.18],0.0734836080599608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,11311,412,1.05 [0.97-1.13],0.2414039482520239
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,9552,341,1.03 [0.82-1.30],0.7736238705259098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,11410,418,1.03 [0.85-1.26],0.7396603699373768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,9747,351,1.14 [1.00-1.31],0.0496796159944635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,9552,341,1.03 [0.96-1.10],0.3691918660837434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,11164,413,0.86 [0.74-1.01],0.068432341177513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,11410,413,0.97 [0.69-1.38],0.8788518648909995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",9656,340,1.06 [0.94-1.19],0.356089631573821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,11311,412,1.03 [0.71-1.49],0.8855621633653992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,11404,419,0.79 [0.58-1.06],0.1124125828617839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,11309,412,1.08 [0.82-1.42],0.5707448517130624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,11123,409,1.11 [1.01-1.22],0.0355080781572025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAX,Protein max,11164,413,1.06 [0.97-1.15],0.1782089293537034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,11545,425,0.97 [0.83-1.13],0.6850652853044559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,9777,345,0.90 [0.82-0.99],0.0306031469816147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,11451,416,1.03 [0.78-1.36],0.82659916127798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",9883,356,1.18 [0.94-1.47],0.148161731907728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,9609,341,0.89 [0.79-1.00],0.0532953534662242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,11350,413,1.09 [0.90-1.31],0.3934346510732022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,9866,351,0.98 [0.66-1.47],0.9397074148545664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,11330,413,1.00 [0.88-1.13],0.9419375591382572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",9855,354,1.15 [0.89-1.47],0.2789869585725588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDK,Midkine,11388,422,0.98 [0.83-1.16],0.8503441288365363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,9644,346,1.17 [0.85-1.63],0.3336050845290889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",9624,345,1.03 [0.92-1.15],0.5962064475797461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,11123,409,1.08 [0.97-1.21],0.1683765761385883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,9580,341,0.89 [0.70-1.12],0.3089647324141384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,11384,418,1.17 [0.95-1.45],0.1474519160009429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,9580,341,1.06 [0.77-1.48],0.7132111469342017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,11504,424,1.41 [0.94-2.11],0.0976656468415111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,9898,356,0.90 [0.64-1.28],0.5638868906662187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,9673,340,1.55 [0.99-2.42],0.0548842754112152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,9866,351,0.88 [0.77-1.01],0.0672682999818025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,11410,413,0.92 [0.86-0.99],0.0273427929459553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,11384,418,0.90 [0.62-1.30],0.5757240581203715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,11557,426,1.12 [0.79-1.60],0.525917756913342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,11395,417,1.03 [0.96-1.11],0.3668769132499615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,11428,422,0.78 [0.49-1.22],0.2776259402325086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,11164,413,1.00 [0.75-1.34],0.9843996666425606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",11410,418,1.06 [0.96-1.18],0.2538722319160027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,11500,427,1.02 [0.88-1.19],0.7766523664375276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,11200,414,1.00 [0.83-1.21],0.98271382666088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,9644,346,0.95 [0.80-1.12],0.5379500777656203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,9673,340,0.90 [0.65-1.26],0.5403168598083601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,11545,425,1.05 [0.85-1.30],0.6604566241737222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,11395,417,0.89 [0.74-1.07],0.2234090939123441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,11430,420,1.06 [0.96-1.17],0.2218682021271457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,11410,418,1.03 [0.96-1.10],0.4858113005168636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,11429,424,1.04 [0.83-1.32],0.7142072019930259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,9644,346,1.07 [0.93-1.24],0.3522430133348286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,11410,418,1.02 [0.96-1.08],0.558911336739828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,11373,417,1.01 [0.89-1.15],0.8352477806744601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,11217,413,0.88 [0.74-1.05],0.1651321488552906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,9864,357,1.06 [0.97-1.17],0.2128715717331249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,9874,353,1.06 [0.95-1.18],0.3253354344725596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,11330,413,1.05 [0.96-1.14],0.3158906406638934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,9609,341,0.96 [0.74-1.24],0.7514131449843791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,9552,341,1.00 [0.86-1.18],0.97230491444903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,11410,418,1.01 [0.92-1.11],0.8504174411605228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,11354,418,0.95 [0.85-1.06],0.3547080490227869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,11040,405,1.02 [0.93-1.13],0.6397720592292995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,11372,418,0.94 [0.80-1.10],0.4198615676908813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,11433,423,0.82 [0.69-0.98],0.0271934822872362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,11164,413,0.95 [0.72-1.27],0.7483178689397367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,9898,356,1.01 [0.82-1.24],0.9081572269356174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,11395,417,1.02 [0.85-1.22],0.8265828710427442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,11187,414,1.01 [0.85-1.21],0.8816093027236771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,11502,426,0.99 [0.88-1.12],0.8637211550719802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,11382,416,0.95 [0.83-1.10],0.5115710968895901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",9580,341,1.03 [0.85-1.26],0.7450756625669137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,9644,346,0.94 [0.77-1.14],0.5188303864149656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,9747,351,0.94 [0.74-1.18],0.5719223615013987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,11393,413,0.99 [0.91-1.08],0.7814603870167992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,9673,340,1.09 [0.94-1.27],0.2726761752147237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,11511,427,1.17 [0.90-1.52],0.245403289761946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,9874,353,1.35 [0.98-1.87],0.0640442962626108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,9747,351,1.02 [0.80-1.30],0.8965321551958125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,9552,341,1.05 [0.80-1.38],0.7256476115260282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,9552,341,1.00 [0.87-1.14],0.9659458781125728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,11200,414,1.04 [0.93-1.17],0.462132078213665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,11354,418,1.02 [0.93-1.13],0.6655084282354939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,11430,420,1.02 [0.91-1.14],0.7360673124232224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,11395,417,0.83 [0.68-1.01],0.0576796966129038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,9851,357,1.16 [0.95-1.42],0.1568540625141507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,9907,357,0.82 [0.57-1.19],0.3048932007402994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,9644,346,1.01 [0.86-1.18],0.8955290916263942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",9580,341,1.06 [0.82-1.37],0.6426346257705368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",9883,356,1.19 [0.95-1.50],0.1342106397100015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",11164,413,1.05 [0.76-1.44],0.7716060931754973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",9530,341,1.30 [0.88-1.94],0.1896777996441329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",9883,356,1.00 [0.86-1.15],0.9604608497938154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",9609,341,0.95 [0.66-1.37],0.7995087210126974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,11337,418,1.02 [0.87-1.20],0.7886336985058837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,9644,346,1.05 [0.78-1.40],0.7477218051176263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,11382,420,0.99 [0.87-1.12],0.8677949984728696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,11520,426,0.80 [0.66-0.96],0.0172846253091282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,11429,424,1.02 [0.91-1.15],0.7215596434251357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,9772,348,0.96 [0.83-1.11],0.6247520865439875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,11200,414,1.02 [0.87-1.20],0.7771160867637282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,9609,341,1.05 [0.94-1.17],0.3897089870836326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",9874,353,1.31 [0.91-1.88],0.1449844579439159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,9747,351,1.04 [0.96-1.14],0.3413135519724634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",9866,351,1.09 [0.97-1.22],0.1273897135170044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,11200,414,0.89 [0.67-1.17],0.398537660704631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,9580,341,0.98 [0.83-1.16],0.8362880679887206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,9866,351,1.03 [0.94-1.13],0.4712876895980253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,9864,357,1.09 [0.98-1.20],0.0972704257852477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,9747,351,0.95 [0.78-1.15],0.5803281762621542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,11164,413,1.06 [0.89-1.25],0.5343563044296433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,11354,418,1.01 [0.97-1.06],0.6263217736891666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,9911,356,0.98 [0.88-1.09],0.667933165927328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,9552,341,1.13 [0.90-1.41],0.2977673580387391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,11217,413,1.01 [0.91-1.12],0.871781375484115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,9673,340,1.75 [1.25-2.46],0.0012042629584531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",9898,356,1.07 [0.94-1.22],0.2823769145589059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",9624,345,0.96 [0.85-1.09],0.5243192144958537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,9883,356,1.09 [0.94-1.27],0.2666161877654068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,9898,356,1.02 [0.93-1.13],0.6475270489210918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,9580,341,0.88 [0.68-1.12],0.292852189602618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,9552,341,0.90 [0.70-1.17],0.4372376268047847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,9911,356,1.00 [0.91-1.09],0.9837209342176612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",9580,341,1.15 [0.92-1.44],0.2070938162774543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,9624,345,1.04 [0.91-1.19],0.5315162580222432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,9624,345,1.02 [0.84-1.24],0.8427622376019279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,9644,346,1.02 [0.91-1.14],0.7147594116159628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",9644,346,1.12 [0.94-1.33],0.2040955359466967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,9883,356,1.10 [0.87-1.39],0.4355365335362195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,11217,413,1.16 [1.02-1.31],0.0194696640628824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,11395,417,1.03 [0.85-1.25],0.7523376995318521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,9574,343,1.06 [0.86-1.30],0.5960379865493908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,9580,341,1.04 [0.87-1.24],0.6877469602412776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,9673,340,1.10 [0.99-1.22],0.0867056495017703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,11421,422,0.90 [0.75-1.07],0.2350474791717786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,11123,409,1.17 [1.00-1.37],0.0527111606657975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,9580,341,1.09 [0.89-1.34],0.3878051145186078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,9644,346,1.05 [0.96-1.14],0.2986288479373222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,11278,409,0.94 [0.81-1.09],0.3973510089515705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,9864,357,1.07 [0.89-1.28],0.4702038326749056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,11410,413,0.88 [0.74-1.03],0.1159252634191063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,9595,341,0.97 [0.82-1.16],0.7614539725119154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,9610,345,1.02 [0.85-1.22],0.8113168890058384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,9673,340,1.21 [0.74-1.97],0.4486910334739754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,11123,409,1.05 [0.90-1.23],0.5292665180505652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,9844,351,1.03 [0.80-1.31],0.8400645502823934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,9874,353,1.33 [1.00-1.76],0.0486157929197203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",9883,356,1.02 [0.82-1.26],0.8702393308747068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,11429,424,1.01 [0.72-1.40],0.9745533538033614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,11217,413,1.03 [0.88-1.21],0.704913721454867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,11451,416,1.06 [0.82-1.38],0.6405671530977866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,11395,417,0.91 [0.66-1.26],0.5865920768827971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,11520,426,0.88 [0.70-1.11],0.2749318638147321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,11384,417,0.94 [0.84-1.04],0.2246479089918108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,11447,423,1.04 [0.96-1.12],0.3613636534457392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,11217,413,0.98 [0.83-1.17],0.842798372425106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,11396,417,0.82 [0.64-1.04],0.1047181053740073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,9866,351,0.76 [0.56-1.03],0.0812566769230163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,11511,427,1.00 [0.73-1.37],0.9901143980297394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,11164,413,1.02 [0.90-1.15],0.7658002765182395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,9864,357,1.05 [0.89-1.24],0.559581755893412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,9586,340,0.98 [0.74-1.30],0.8967565521338966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,9866,351,1.04 [0.93-1.17],0.4802117532753979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",11123,409,1.01 [0.90-1.13],0.833515068611802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,9580,341,1.10 [0.85-1.42],0.4595314010522022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,9580,341,0.95 [0.80-1.12],0.5223968157397048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,9609,341,0.90 [0.65-1.24],0.5260582317664017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,11400,413,0.79 [0.58-1.08],0.1431111409151187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,11429,424,0.79 [0.59-1.07],0.1295923685120168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,9609,341,1.06 [0.85-1.32],0.5899480994101032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,9609,341,0.82 [0.60-1.13],0.2287921892960131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,11130,412,0.91 [0.74-1.12],0.3940498618766105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,9747,351,1.04 [0.91-1.19],0.5303347051852655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,11429,424,1.39 [1.13-1.70],0.0015130074970006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,11447,423,0.84 [0.62-1.15],0.2816554785154596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,9864,357,1.02 [0.93-1.11],0.7062918178291466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,9883,356,0.66 [0.42-1.06],0.0876522542057951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,9907,357,1.05 [0.91-1.21],0.5255337504895358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,11557,426,0.82 [0.60-1.12],0.202202243854291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,9609,341,1.04 [0.92-1.17],0.5555705647931655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",11410,418,1.03 [0.95-1.13],0.4558564047978762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",11217,413,1.05 [0.91-1.21],0.5185720603499175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,9624,345,1.08 [0.94-1.24],0.2965276959643509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,9883,356,0.92 [0.71-1.20],0.559071336611737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,9580,341,0.98 [0.85-1.12],0.7517455958237281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,9747,351,1.06 [0.90-1.26],0.4574886914318449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,11123,409,1.18 [0.99-1.40],0.0606874604140741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",9866,351,1.03 [0.93-1.14],0.5538768467471558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,9580,341,0.97 [0.83-1.14],0.7269269888134182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,9580,341,0.97 [0.74-1.28],0.8326759991842997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,11330,413,1.09 [0.55-2.16],0.8102887898182594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,9898,356,1.14 [0.83-1.58],0.4084747654984064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,9874,353,1.18 [0.75-1.85],0.4834022051487366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,9472,332,0.95 [0.67-1.34],0.7702636098590295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,11417,414,0.92 [0.72-1.16],0.4795139438288577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,11395,417,1.00 [0.89-1.12],0.949169987156473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,11123,409,1.06 [0.91-1.24],0.4562643126349929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,9624,345,1.01 [0.80-1.28],0.9185184702612876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,9853,353,1.04 [0.90-1.19],0.5984360114100851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,9644,346,1.00 [0.86-1.17],0.996751118166043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,9574,343,1.07 [0.86-1.33],0.5309055609631224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,9609,341,1.28 [0.80-2.06],0.3021672921180527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,11404,419,0.76 [0.52-1.13],0.1784853794909671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,9817,355,1.09 [0.96-1.25],0.1881389970548895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,11330,413,1.02 [0.91-1.14],0.7382032316301782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,9552,341,1.01 [0.78-1.31],0.9310883738491424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,9883,356,1.09 [0.95-1.25],0.2325395323572707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,11395,417,0.79 [0.55-1.13],0.2004162131303465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,9580,341,0.95 [0.86-1.05],0.3123037067802143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",11164,413,1.07 [0.93-1.24],0.344208379098032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",9580,341,0.82 [0.63-1.08],0.1639310626894333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",11164,413,0.82 [0.68-1.00],0.0491430323835392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,11545,425,0.96 [0.55-1.67],0.8836662627517875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,9911,356,1.15 [0.74-1.77],0.5342636134271912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,11545,425,0.95 [0.73-1.23],0.705674043569993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,9744,352,0.98 [0.69-1.38],0.8983541922334526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,11410,413,0.79 [0.58-1.08],0.1426399811899472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,9609,341,1.36 [1.03-1.80],0.0310484543661807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,9609,341,0.97 [0.87-1.07],0.5186574157419552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,9898,356,0.85 [0.68-1.07],0.1564846139704636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,11200,414,1.02 [0.96-1.10],0.5179616639488815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,11410,418,0.93 [0.78-1.10],0.3791906452315939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,9580,341,1.19 [0.95-1.48],0.1253015927676564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,11123,409,1.02 [0.91-1.14],0.6889296421602515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,11395,417,0.92 [0.74-1.14],0.4344225524465388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,9911,356,1.04 [0.77-1.41],0.7837336672468307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,11410,413,1.16 [0.91-1.49],0.2234698399332541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,11511,427,0.96 [0.84-1.10],0.5673111199750089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,11410,413,0.83 [0.61-1.15],0.2634176438306961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,9907,357,1.03 [0.93-1.15],0.568732764662671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,9883,356,1.01 [0.78-1.32],0.9212294439775464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,11476,417,0.99 [0.72-1.36],0.932344384001623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,11395,417,0.76 [0.55-1.04],0.0836159670629495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,11217,413,1.11 [0.95-1.31],0.1880791380562391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,9644,346,1.00 [0.74-1.33],0.975090111619765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,11520,426,1.03 [0.90-1.18],0.6480185920799542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",9898,356,1.11 [0.97-1.28],0.1139657424875557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,9874,353,0.89 [0.63-1.26],0.5113781547277247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,11385,417,1.08 [0.98-1.19],0.136777707452238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,11429,424,0.86 [0.73-1.01],0.0604317804097293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,11410,418,0.86 [0.66-1.11],0.2403512634161385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,11123,409,0.96 [0.75-1.22],0.7285026192076656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,11410,413,0.92 [0.65-1.32],0.6638184287358739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,11520,426,1.48 [0.99-2.22],0.0562329841285908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,11410,413,1.03 [0.94-1.13],0.4746873195789862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,11410,418,1.06 [0.96-1.17],0.2447162617955789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,9864,357,1.05 [0.95-1.15],0.3468287784724588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,11501,427,1.10 [0.88-1.38],0.3916319863083888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,11557,426,1.02 [0.90-1.17],0.7261289049464408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,9624,345,1.10 [0.74-1.62],0.6346208217431724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,9580,341,1.10 [0.90-1.34],0.3724414095129675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,9853,351,1.03 [0.92-1.16],0.5601366413247061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],11354,418,0.94 [0.81-1.10],0.4542879167830101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,11395,417,1.05 [0.88-1.24],0.589104982125394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,9609,341,1.06 [0.93-1.20],0.3744155287897587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,9580,341,1.10 [0.80-1.50],0.5636666300330351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,9580,341,1.01 [0.73-1.39],0.943323318623674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,11164,413,1.04 [0.83-1.31],0.7041051684126677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,9609,341,0.95 [0.67-1.34],0.7605395120364898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,11291,411,1.08 [0.92-1.25],0.3579197223262692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,9883,356,1.06 [0.83-1.35],0.63631067425379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,11145,412,1.15 [0.99-1.33],0.0603237088494619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,9747,351,0.91 [0.76-1.08],0.2688790418822072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,9866,351,1.14 [0.99-1.31],0.0761464336345148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,11354,418,0.99 [0.76-1.29],0.9333700828635474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,11395,417,0.89 [0.71-1.11],0.2829908447742701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,9747,351,0.99 [0.84-1.15],0.8529546934685239
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,9320,324,0.98 [0.90-1.07],0.5941412476443032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,11303,410,0.93 [0.81-1.08],0.3631856325690873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,11447,423,0.96 [0.78-1.19],0.7295454029834112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,11354,418,0.97 [0.86-1.10],0.6827499601663988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,9574,343,0.88 [0.70-1.12],0.307860842529759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,9874,353,1.03 [0.94-1.13],0.5415639893944811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,9624,345,1.11 [0.96-1.28],0.1552715236882201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,11354,418,0.84 [0.68-1.03],0.1010411140295813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,9874,350,1.53 [0.93-2.54],0.0969189984348235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,9874,353,1.22 [0.96-1.55],0.1078931471830094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,11404,419,0.83 [0.64-1.07],0.1432655094734698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,11351,417,0.92 [0.81-1.04],0.1752514248095321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,11476,417,0.62 [0.39-0.98],0.0411400782110673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,9644,346,1.16 [0.91-1.47],0.2263877828668178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,9574,343,1.02 [0.83-1.24],0.86630497891856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,9866,351,1.10 [0.92-1.31],0.2861365569023125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,9883,356,1.11 [0.95-1.30],0.1822213631912269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",9624,345,1.04 [0.90-1.20],0.6327443695435738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,11520,426,0.99 [0.94-1.06],0.8582915396163473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,11340,420,1.06 [0.85-1.32],0.5941855893726028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,9580,341,1.00 [0.85-1.18],0.978302774238374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,11217,413,1.04 [0.90-1.19],0.6116645101638796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,11145,412,1.00 [0.89-1.12],0.9457222542177168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,11330,413,0.98 [0.90-1.07],0.6271984054830503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,9883,356,1.00 [0.92-1.09],0.9792653250654938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",9747,351,1.12 [0.91-1.36],0.2891455506640635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,11200,414,0.96 [0.82-1.13],0.642899590020696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,9624,345,0.95 [0.74-1.21],0.6790851419845727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,9532,341,0.96 [0.79-1.17],0.6955262746172967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,11164,413,1.02 [0.89-1.17],0.7551478652662947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,9609,341,0.85 [0.63-1.14],0.2786056337103365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,9806,349,0.81 [0.59-1.12],0.1970340884711148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,9874,353,0.85 [0.64-1.12],0.2390854821147279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,9580,341,1.01 [0.89-1.15],0.8823471577802147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,11494,424,0.92 [0.68-1.26],0.6115402114588611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,11395,417,0.95 [0.69-1.31],0.7494766916724706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,11217,413,0.98 [0.81-1.18],0.8160825937806178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,9747,351,1.06 [0.93-1.21],0.3900927925513539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,11395,417,1.02 [0.86-1.21],0.804347803235749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,11410,418,1.01 [0.86-1.17],0.9439617781517082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,9673,340,1.03 [0.82-1.28],0.8253407310185676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,9552,341,0.92 [0.66-1.29],0.626679038273884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,11164,413,1.02 [0.86-1.20],0.8508213237682667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,9866,351,1.16 [0.84-1.63],0.3686475138934503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,9574,343,0.83 [0.71-0.97],0.0164324410118094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,9651,339,0.86 [0.69-1.08],0.1920302045362532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,9883,356,1.08 [0.94-1.24],0.2898952892871412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,11516,426,0.97 [0.65-1.47],0.9026802252731788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,9883,356,1.05 [0.71-1.56],0.7991933813840557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,11410,413,0.75 [0.58-0.96],0.0212807593840514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,9866,351,0.99 [0.74-1.32],0.9234099355303454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,9866,351,1.10 [0.81-1.48],0.5500239995190321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,9864,357,1.04 [0.81-1.34],0.739230687634608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,9552,341,0.99 [0.85-1.16],0.9330349379582672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,9864,357,0.98 [0.78-1.23],0.833973055734046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,11545,425,0.77 [0.62-0.95],0.0153312828083175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,9866,351,1.01 [0.88-1.15],0.9384097649110014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,9898,356,1.02 [0.92-1.12],0.7730949059888556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,11491,425,0.94 [0.75-1.18],0.5881156583400713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,11354,418,0.91 [0.69-1.21],0.5142794157266539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,11520,426,1.06 [0.92-1.23],0.4122678517435658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,11410,413,1.07 [0.94-1.22],0.3202689727259273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,9552,341,1.18 [1.00-1.40],0.054480086046149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",9552,341,0.91 [0.73-1.13],0.3947064758735672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",9580,341,0.99 [0.83-1.17],0.8717245604885284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",9673,340,1.03 [0.93-1.14],0.5297625864757647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,11545,425,0.98 [0.88-1.11],0.7819196419013708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,11447,423,0.99 [0.89-1.09],0.7811377929386187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,11123,409,1.19 [0.88-1.61],0.268589315966287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,11410,413,0.69 [0.50-0.95],0.02349342209264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,11545,425,0.93 [0.73-1.18],0.5485972094600997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,9552,341,1.08 [0.84-1.39],0.5375398037752939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,9673,340,1.39 [0.94-2.06],0.0966652097762703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,9911,356,1.10 [0.94-1.29],0.2337239736986106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,9552,341,0.95 [0.80-1.13],0.5512232920011887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,9883,356,1.04 [0.96-1.14],0.3281732706022547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,11447,423,1.05 [0.98-1.12],0.1358491959500818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",11123,409,1.06 [0.90-1.26],0.462309631353902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,9644,346,1.08 [0.90-1.31],0.3903035101567449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,9552,341,1.13 [0.95-1.35],0.1685337048201622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,9580,341,1.06 [0.89-1.26],0.540434896236923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,9609,341,0.81 [0.63-1.04],0.0968967945768901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,11545,425,1.36 [0.94-1.98],0.1048828373876311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,11395,417,0.97 [0.83-1.13],0.6711035886277346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,11395,417,1.03 [0.78-1.37],0.8172058907134696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,9624,345,1.28 [0.93-1.76],0.1346265760160639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,9673,340,0.89 [0.62-1.28],0.5431092955036559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,9907,357,1.33 [0.91-1.95],0.1460847646200879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,9609,341,1.02 [0.94-1.12],0.5942731334869809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,9833,348,1.01 [0.91-1.13],0.7870323170837787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,11164,413,1.07 [0.92-1.26],0.3753741096226832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,9552,341,1.14 [0.96-1.35],0.1319645155948482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,9644,346,0.99 [0.85-1.16],0.9194390203117898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",11338,417,1.01 [0.90-1.13],0.9047634047460256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,9907,357,1.10 [0.94-1.28],0.2557930091821774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",9898,356,1.04 [0.86-1.25],0.7116963131108693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,11557,426,0.83 [0.57-1.20],0.3257600846948693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,11485,424,0.89 [0.72-1.10],0.2862840708609514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,9784,344,0.97 [0.68-1.38],0.8723241576022496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,9580,341,0.97 [0.81-1.16],0.7076273519522376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,9644,346,0.97 [0.81-1.17],0.7842889495330445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,9609,341,1.01 [0.91-1.11],0.8886033180597559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,9883,356,1.04 [0.95-1.13],0.4080902200767242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,9866,351,1.03 [0.85-1.25],0.735834487351861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,9552,341,0.94 [0.83-1.06],0.3327657042027465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,11330,413,1.00 [0.74-1.33],0.9802175184320572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,9673,340,1.13 [0.88-1.45],0.3524581236333032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,9907,357,0.99 [0.65-1.52],0.9602326678230088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI3,Elafin,11242,412,0.98 [0.83-1.15],0.8042272853892024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",9883,356,1.11 [0.98-1.26],0.1131015753590117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,11255,410,0.83 [0.65-1.05],0.1209285154531619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,11410,418,1.06 [0.92-1.22],0.4148864042983831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,11395,417,0.87 [0.62-1.24],0.4456035374705204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,9609,341,0.95 [0.79-1.15],0.6028642763630648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,11395,417,0.77 [0.63-0.95],0.0166498766373858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,11410,413,0.89 [0.77-1.04],0.1521205109910006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,9673,340,1.05 [0.90-1.22],0.5338254601992664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,9532,341,0.98 [0.84-1.13],0.7568310160306333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,9898,356,1.06 [0.71-1.57],0.7783359938901546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,9580,341,0.97 [0.81-1.16],0.7070793584663858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,11407,420,0.95 [0.83-1.09],0.4762895306536553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,9747,351,0.99 [0.86-1.14],0.8632801850739856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,11330,413,1.03 [0.88-1.19],0.730230055607908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,11429,424,0.91 [0.67-1.24],0.5477857070860882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,11526,423,0.94 [0.77-1.15],0.5340954389277696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",11382,417,0.90 [0.76-1.07],0.2452871093096243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,11447,423,1.06 [0.96-1.17],0.2355278536926725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,11395,417,0.79 [0.61-1.04],0.0927829481485631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,11504,424,0.87 [0.74-1.03],0.1109024735027171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,11395,417,0.95 [0.69-1.30],0.734243847033181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,11308,416,1.14 [0.83-1.57],0.4061252043194604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",9874,353,1.21 [1.01-1.44],0.0334271448799748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",9609,341,0.99 [0.77-1.26],0.9157528599891234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",9874,353,1.02 [0.92-1.12],0.7617497698016995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,9874,353,1.08 [0.94-1.25],0.2709666297739088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,9665,341,1.00 [0.61-1.63],0.9948543834202054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,11164,413,0.88 [0.67-1.14],0.3325087466843392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,11410,413,1.08 [0.88-1.31],0.4663497975396039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,11410,413,1.04 [0.91-1.18],0.5708075061586424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,9854,351,1.16 [0.98-1.38],0.0909231479259294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,11507,424,1.32 [1.04-1.66],0.0209568414665347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,11123,409,1.17 [0.96-1.43],0.1175446243826981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,9874,353,0.88 [0.60-1.28],0.4940804299142102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,11410,418,1.04 [0.93-1.16],0.4908409222648333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,11491,424,0.63 [0.43-0.91],0.0148411547132067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,11370,411,1.13 [0.95-1.35],0.1689405347285575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,11370,410,1.04 [0.99-1.09],0.0894590152862035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,9580,341,1.03 [0.91-1.17],0.6066499812967252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,9580,341,1.07 [0.90-1.27],0.4382240053243129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,9644,346,0.96 [0.78-1.18],0.6912553744698351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,11146,412,1.01 [0.93-1.09],0.8209847141859044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,9907,357,1.04 [0.90-1.21],0.5759655928886767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,9874,353,0.99 [0.88-1.12],0.9077515279711283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,11384,418,1.00 [0.97-1.03],0.9123780373157702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,9624,345,1.08 [0.91-1.27],0.393991613169675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,9574,343,0.99 [0.78-1.27],0.964455572177217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",11217,413,0.95 [0.88-1.02],0.1767098099515268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,11354,418,1.08 [0.61-1.91],0.7868331003804411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,11429,424,0.93 [0.68-1.26],0.6329264673263453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,9609,341,0.87 [0.68-1.12],0.2865270893124119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,9609,341,0.84 [0.59-1.20],0.335409409846304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",11354,418,0.87 [0.66-1.14],0.3027565280697049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,9624,345,0.88 [0.76-1.02],0.0909974777992777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,9907,357,1.48 [0.98-2.22],0.0604676089682179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,11200,414,0.93 [0.73-1.20],0.5863098471274131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,11447,423,1.07 [0.80-1.42],0.6522840070718012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,9911,356,0.95 [0.72-1.26],0.7214000630541064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,9830,347,1.01 [0.90-1.14],0.8274999679289945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,11520,426,1.06 [0.88-1.26],0.5433100279845146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,11404,422,1.03 [0.95-1.13],0.4695067580270925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,9747,351,1.04 [0.88-1.22],0.6453590644660936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",9911,356,1.09 [0.94-1.27],0.2339928333544971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,9609,341,0.88 [0.63-1.23],0.4626647719635651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,11123,409,0.88 [0.66-1.18],0.3886489628337881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,9609,341,1.03 [0.88-1.21],0.7069522801520912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,9898,356,1.12 [0.93-1.34],0.241704158877163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,11354,418,1.00 [0.87-1.16],0.9831923522066928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,9864,357,1.15 [1.02-1.29],0.0216369181527908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,11429,424,1.03 [0.94-1.12],0.5616418299830184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,9747,351,1.06 [0.92-1.22],0.3986048954416055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,9883,356,1.07 [0.95-1.22],0.26685951792287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,9883,356,0.93 [0.70-1.23],0.5945694732251091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,11410,413,1.07 [0.96-1.19],0.2177199106508472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,11557,426,1.07 [0.98-1.17],0.1250197948224866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,9866,351,1.06 [0.97-1.15],0.1873327223315382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,11330,413,1.14 [0.93-1.41],0.2068225827488846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,9644,346,1.02 [0.89-1.16],0.7788021256486821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,11356,422,1.07 [0.98-1.16],0.1146944136480891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,11123,409,0.91 [0.77-1.08],0.2611985823773282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,9552,341,1.42 [0.97-2.10],0.0724088941993139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,9911,356,0.78 [0.61-1.01],0.0558134018747599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,9864,357,0.99 [0.78-1.26],0.9402190934746671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,11466,420,0.84 [0.64-1.11],0.2270854845586656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,11095,400,1.08 [0.98-1.19],0.1022266842331085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,9756,349,1.01 [0.86-1.19],0.904848816804195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",11217,413,1.07 [0.95-1.21],0.2701286293473408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",11557,426,1.03 [0.91-1.17],0.6581528076168341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,11511,427,1.05 [0.91-1.21],0.532907283682519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,11217,413,1.00 [0.74-1.36],0.9917682441772974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,11384,418,1.18 [0.79-1.76],0.4118177691745487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,9911,356,0.94 [0.77-1.15],0.545335051230603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,9911,356,0.79 [0.65-0.96],0.0163927467666074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,11217,413,1.07 [0.92-1.25],0.3918614478378311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,9644,346,1.34 [0.99-1.83],0.061422645877782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,11410,413,1.02 [0.92-1.13],0.6910934863408491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,9852,351,1.02 [0.90-1.16],0.758796560827039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,11217,413,0.92 [0.74-1.14],0.4507948866277497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,9580,341,0.95 [0.74-1.22],0.6671918790693376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,9673,340,1.06 [0.97-1.15],0.193527207200951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,11123,409,1.08 [0.95-1.23],0.2445574060276741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,11520,426,1.13 [1.00-1.26],0.0408534445520794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,9874,353,0.91 [0.73-1.13],0.377976729497736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,11439,415,1.01 [0.72-1.42],0.9515223741880536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,9580,341,0.99 [0.73-1.33],0.9409101988468292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,11410,418,1.16 [0.98-1.38],0.0829614975602784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,9909,351,0.96 [0.63-1.48],0.8646512378181709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,9605,340,1.06 [0.91-1.22],0.4628652731737288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,9609,341,1.16 [0.94-1.44],0.1556303735635767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,9624,345,1.01 [0.76-1.33],0.9677589548269662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,11451,416,1.00 [0.86-1.18],0.9531902160134412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,9609,341,0.84 [0.61-1.16],0.3007559241191316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,11369,412,0.85 [0.68-1.06],0.1423347984106839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,9874,353,0.92 [0.72-1.17],0.4845348391384192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,11354,420,0.91 [0.74-1.13],0.3838531247596728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,11164,413,1.05 [0.97-1.14],0.1961877886024589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,11511,427,1.39 [0.99-1.97],0.0601848891793027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,11132,415,0.97 [0.80-1.16],0.7146036245113656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,9747,351,0.78 [0.53-1.15],0.2076395114381798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,9824,353,1.00 [0.68-1.46],0.997495245310653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,9866,351,1.03 [0.84-1.26],0.7905739162318407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,9866,351,1.01 [0.97-1.05],0.5273125382959851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,11330,413,1.03 [0.95-1.12],0.525082153846627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,11410,418,1.09 [0.97-1.24],0.1573867291138837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,11123,409,1.03 [0.85-1.24],0.7647455191952577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,9552,341,1.29 [0.92-1.80],0.1352327992663873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,9883,356,1.03 [0.85-1.26],0.7476610641631827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,9644,346,1.11 [0.92-1.34],0.2819178732721207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,11354,418,0.94 [0.80-1.10],0.4165082452673039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,11320,412,1.09 [0.86-1.38],0.4956773021129821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,11282,412,1.05 [0.82-1.34],0.6985929503801394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,11410,418,0.97 [0.82-1.16],0.7431626805443892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,9609,341,0.97 [0.81-1.17],0.7844337786119946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,11410,418,0.98 [0.89-1.09],0.7369779406345858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,11123,409,0.99 [0.86-1.15],0.9087960159334778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,9322,325,1.02 [0.92-1.13],0.6983584025250122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",11164,413,0.91 [0.68-1.21],0.5050689966614998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,11329,413,0.81 [0.59-1.11],0.1857931075251015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,9537,337,1.10 [0.91-1.33],0.3036645212781708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,9898,356,1.01 [0.89-1.14],0.9281655200161372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,9644,346,1.00 [0.88-1.14],0.9639539744109604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,11410,418,0.89 [0.69-1.14],0.3560962432743975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,11164,413,0.97 [0.77-1.23],0.8268838839293128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,11200,414,1.06 [0.89-1.26],0.5261520860370157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,9609,341,0.99 [0.81-1.22],0.9603205661800776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,11330,413,1.11 [0.99-1.23],0.0668403518414159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,11430,420,1.05 [0.96-1.16],0.2798726149091209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,9592,341,1.02 [0.79-1.33],0.8591067047021109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,9898,356,1.06 [0.75-1.49],0.7409541800876349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,9911,356,1.34 [0.85-2.10],0.2129372075316483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,11545,425,1.16 [0.85-1.59],0.3377448401446957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,9866,351,0.84 [0.68-1.04],0.1036788085672062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,9866,351,1.12 [0.71-1.76],0.6369672923881557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,11390,418,1.07 [0.75-1.51],0.7185692231878276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,11291,412,1.15 [0.87-1.52],0.3124883221831155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,9874,353,0.97 [0.74-1.29],0.8577382105940906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,11545,425,0.97 [0.69-1.37],0.8663823135626717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,9898,356,1.14 [0.81-1.61],0.4516996172483541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,9673,340,1.13 [0.95-1.34],0.1782565378758523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,11110,412,0.92 [0.78-1.09],0.3340259845662449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,9747,351,0.87 [0.67-1.12],0.2831344078100922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,11410,418,0.83 [0.71-0.98],0.0274640703820529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,11472,426,0.99 [0.92-1.06],0.6953833501014625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,11520,426,0.90 [0.72-1.13],0.3734149994448247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,9864,357,1.12 [0.97-1.29],0.1150152522162395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,11164,413,0.94 [0.79-1.11],0.4460712431162142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,9624,345,0.92 [0.70-1.20],0.5232079348212433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,9580,341,0.97 [0.87-1.08],0.563050330593746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,9909,351,1.08 [0.78-1.48],0.6545582993247689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,11349,413,1.01 [0.82-1.23],0.9561877394577836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,11399,419,0.70 [0.52-0.94],0.0184546906747327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,9710,344,0.84 [0.61-1.17],0.309948360467755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,9898,356,1.17 [0.98-1.41],0.0858782018940772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,9898,356,1.03 [0.94-1.13],0.5768482445992529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,9898,356,1.03 [0.91-1.16],0.6815861700727902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,9864,357,1.09 [0.93-1.27],0.2985611668721794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,9580,341,1.03 [0.89-1.20],0.6822438223639833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,11217,413,0.93 [0.84-1.04],0.2273904848457875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,9580,341,0.97 [0.86-1.10],0.6439195966324782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,9574,343,0.99 [0.83-1.19],0.955523654986196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,9864,357,1.04 [0.85-1.27],0.7299174583801958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,11410,418,1.28 [1.07-1.54],0.0078569122128663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,11164,413,1.07 [0.89-1.28],0.4896245203193109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,9673,340,1.08 [0.94-1.24],0.2709964416043136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,11123,409,0.92 [0.79-1.07],0.2684375112943455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,11217,413,0.99 [0.85-1.15],0.8798020425410784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,9644,346,1.01 [0.87-1.18],0.913507152753831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,11123,409,1.12 [0.93-1.35],0.2377723135508374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,9747,351,1.00 [0.82-1.21],0.9952399311740252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,9609,341,0.82 [0.58-1.17],0.2726172665744059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,9864,357,0.99 [0.80-1.22],0.9132189138122748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,9624,345,1.05 [0.86-1.28],0.6376019591759212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,9574,343,0.88 [0.63-1.21],0.4220584361260228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,11123,409,0.94 [0.79-1.14],0.5411759386973365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,9609,341,1.02 [0.88-1.20],0.7636258039352695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,9747,351,1.16 [0.96-1.40],0.1150802239160216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,11123,409,1.04 [0.80-1.35],0.76107735157886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,11476,417,0.89 [0.74-1.06],0.1878698884546069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,11164,413,1.09 [0.85-1.39],0.5198931028075429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,9552,341,1.14 [0.90-1.43],0.2805314107028449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,11123,409,0.89 [0.76-1.05],0.1814766807699754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,9883,356,0.86 [0.65-1.14],0.2879084510041662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,11161,404,0.85 [0.72-1.02],0.0771047298828793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,9883,356,1.07 [0.94-1.22],0.2733102851094132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,9580,341,1.10 [0.89-1.37],0.3569358856232578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,9552,341,1.04 [0.83-1.32],0.714215679358196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,9644,346,0.95 [0.82-1.11],0.5063451226563173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,11354,418,1.01 [0.90-1.13],0.9081217639133288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,11354,418,0.95 [0.81-1.10],0.4793682261079764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,9866,351,1.01 [0.86-1.18],0.9073198690648152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,9609,341,0.97 [0.83-1.14],0.7118405293448108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,9624,345,1.03 [0.93-1.14],0.5358075627626607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,9864,357,0.98 [0.80-1.21],0.8741366948235223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,11200,414,1.17 [1.00-1.38],0.0502071574620705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,9624,345,1.19 [0.73-1.94],0.4764397288504582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,9883,356,1.07 [0.91-1.25],0.4088990873418534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,11345,412,0.82 [0.67-1.00],0.0457837883630632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,11545,425,0.91 [0.77-1.07],0.2384801649880035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,11545,425,0.91 [0.78-1.05],0.1979606445996498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,9864,357,0.93 [0.71-1.22],0.6122774828995938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,11404,419,0.98 [0.82-1.17],0.810362024828558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,9609,341,1.01 [0.81-1.27],0.9123049277812232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,11395,417,1.02 [0.74-1.41],0.8953185086707263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,11410,413,0.82 [0.72-0.94],0.0030898131747532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,9609,341,1.18 [0.91-1.54],0.2069668376045231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,9552,341,1.32 [0.99-1.75],0.0561973159550049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,11354,418,1.00 [0.78-1.27],0.9796420509080316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RETN,Resistin,11384,418,0.93 [0.76-1.15],0.5247785861031299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",9580,341,0.99 [0.79-1.24],0.928902337178016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,9864,357,1.50 [1.01-2.24],0.044948000624874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,9883,356,1.03 [0.90-1.17],0.6823907163672457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,9747,351,1.12 [0.97-1.29],0.1311602790043932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,11520,426,0.99 [0.76-1.30],0.9642709991567282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,11520,426,0.99 [0.71-1.37],0.9364963970867026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,9883,356,1.06 [0.90-1.25],0.4977577718895657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,11217,413,0.78 [0.66-0.92],0.0038967675541545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,11273,410,1.04 [0.96-1.12],0.3389864113492671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,9609,341,0.92 [0.73-1.16],0.4935550451123142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,9673,340,0.91 [0.73-1.12],0.3601538367821454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,11484,426,1.00 [0.87-1.15],0.9905425756419248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,9898,356,1.05 [0.95-1.16],0.3747758475476026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,9580,341,1.00 [0.86-1.18],0.961124474500937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,9883,356,0.97 [0.77-1.23],0.7951429577328206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,9657,340,1.30 [1.07-1.58],0.00969240113066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,9907,357,1.19 [0.78-1.82],0.4142929388487544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,9624,345,1.03 [0.83-1.29],0.7707003998427258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,11352,412,0.98 [0.91-1.06],0.639716858580597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,9605,346,0.89 [0.59-1.33],0.5676295156496146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,9842,354,0.87 [0.59-1.27],0.4677214021836611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,9883,356,1.04 [0.86-1.27],0.6795248893759405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,11489,421,0.89 [0.64-1.25],0.4959070979729143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,9624,345,0.66 [0.46-0.93],0.0195317275821111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,9609,341,0.98 [0.77-1.26],0.8911365694377189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,9609,341,0.95 [0.70-1.27],0.7182797548029841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,9747,351,0.93 [0.79-1.09],0.3700695586967617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,11123,409,1.09 [0.96-1.24],0.1783227132842526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,9747,351,0.82 [0.66-1.03],0.0878793733061651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,9624,345,1.01 [0.87-1.16],0.9071474238156452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,11404,419,0.89 [0.61-1.31],0.5634969947387081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,11520,426,0.99 [0.67-1.46],0.966237871770264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,9624,345,1.05 [0.59-1.86],0.8754881213219446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,11410,413,0.94 [0.71-1.25],0.6771124002915931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,11354,418,1.00 [0.82-1.23],0.9740910631335736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,9609,341,1.24 [0.90-1.72],0.1881585413957964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,9747,351,1.04 [0.91-1.20],0.5410738288687871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,9644,346,1.21 [0.96-1.53],0.1014141737955958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,9624,345,0.96 [0.74-1.26],0.7880448673190908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,9580,341,1.10 [0.87-1.40],0.4081559484590841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,9644,346,1.06 [0.98-1.14],0.1538804917148869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,11123,409,0.92 [0.76-1.11],0.3858094522280596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,11123,409,1.04 [0.92-1.18],0.5334949894822385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,9574,343,0.98 [0.87-1.10],0.7433965610474762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,11330,413,0.90 [0.70-1.17],0.4461492240894744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,11511,427,1.19 [0.86-1.64],0.3068541451698746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,11354,418,0.91 [0.68-1.24],0.5603735762636454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,9580,341,0.91 [0.74-1.13],0.4086312321569315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",9883,356,1.06 [0.96-1.19],0.2568211684186068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,11511,427,0.93 [0.72-1.21],0.5854759607481586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,11123,409,1.01 [0.93-1.11],0.7471279115476419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,11520,426,1.06 [0.92-1.21],0.421427961408461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,9580,341,0.84 [0.60-1.17],0.2972515324554183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,11323,413,0.83 [0.68-1.02],0.0796158793683863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,11234,414,0.94 [0.84-1.06],0.3503359604892437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,9609,341,0.87 [0.64-1.17],0.3505331517866823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,9883,356,1.16 [0.97-1.40],0.1111785945287791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,11145,412,1.02 [0.88-1.17],0.8035490599868644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,9864,357,1.14 [0.94-1.39],0.1783782032388687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,11429,424,1.00 [0.86-1.17],0.9832347700350518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,9883,356,1.12 [0.91-1.38],0.2933052284645772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,11200,414,0.86 [0.72-1.01],0.0716934086031124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,9909,351,0.89 [0.61-1.32],0.5741060080862106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,9883,356,1.45 [1.04-2.00],0.0261128338194018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,9574,343,0.99 [0.81-1.22],0.9364689430912948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,11410,418,1.07 [0.96-1.20],0.2322032825705988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,9747,351,1.00 [0.87-1.15],0.9931629636966144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,9869,354,1.05 [0.96-1.15],0.2660085063613924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,9580,341,0.86 [0.64-1.16],0.3151126657118944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,9580,341,0.92 [0.73-1.15],0.454058450670797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,9747,351,1.07 [0.94-1.23],0.2973209385430867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,9883,356,1.21 [0.87-1.68],0.2593069721043208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,9897,356,0.98 [0.73-1.31],0.8669584106072034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,11354,418,1.04 [0.94-1.15],0.4588083316303216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,11520,426,1.06 [0.79-1.43],0.6918905242994952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,11164,413,0.89 [0.75-1.07],0.2205786724389566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,11105,402,0.86 [0.62-1.20],0.372997748252131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,11545,425,1.00 [0.82-1.22],0.9991940205788624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,11520,426,0.93 [0.67-1.29],0.6650784618226245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,11474,426,0.79 [0.60-1.05],0.1033058058371438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,11404,419,0.84 [0.65-1.09],0.1963723624962441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,11415,422,0.98 [0.83-1.16],0.8280712481206363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,9580,341,1.10 [0.80-1.53],0.5517421602041502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,9673,340,1.40 [0.93-2.12],0.1097243055498817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,11430,420,1.08 [0.97-1.21],0.1514833225556298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,11217,413,0.86 [0.70-1.06],0.1593653086092817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,9574,343,0.96 [0.83-1.11],0.5886356806350326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,11484,426,0.93 [0.78-1.11],0.4303571620634197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,9574,343,0.80 [0.62-1.03],0.0803329990383387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,9644,346,1.03 [0.71-1.50],0.8616270596995106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,9644,346,0.83 [0.60-1.13],0.2355210284087929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,9574,343,1.03 [0.82-1.29],0.7932393891898136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,9624,345,0.90 [0.70-1.15],0.3797971246768874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,11123,409,0.85 [0.74-0.96],0.0124759902028888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,9595,345,1.00 [0.82-1.23],0.9614087962784584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,9898,356,1.16 [0.82-1.64],0.3864205697584338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,9624,345,0.98 [0.87-1.11],0.7650158619208436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,11410,418,1.03 [0.88-1.20],0.7139503131578306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCT,Secretin,9644,346,0.92 [0.73-1.17],0.4998217987811199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,11410,413,0.78 [0.62-0.99],0.0416912949114147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,11410,413,1.11 [0.91-1.34],0.2985270105706722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,9864,357,1.05 [0.96-1.14],0.2962070829193557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,9866,351,1.03 [0.88-1.19],0.7335625144951724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,9673,340,1.23 [0.93-1.62],0.1513871464647067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,9624,345,1.03 [0.90-1.18],0.6374891662949818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,9624,345,0.76 [0.52-1.12],0.1631929127540549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,11545,425,0.94 [0.79-1.12],0.481453151464475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,9909,351,1.09 [0.70-1.70],0.7091427669272703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,9909,351,1.77 [1.16-2.72],0.0087037280668681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,11451,416,1.00 [0.86-1.17],0.9695592624997847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,11410,418,0.88 [0.66-1.18],0.4061958327103954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,11410,413,0.69 [0.49-0.97],0.0319332319805899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,9673,340,1.17 [0.93-1.46],0.1730627520872091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,11354,418,0.91 [0.66-1.25],0.5512824155133527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,11520,426,1.23 [0.93-1.63],0.146533965244365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,9609,341,0.85 [0.56-1.27],0.4190953535240524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,11504,424,0.88 [0.64-1.22],0.4541353100024528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,9883,356,0.95 [0.83-1.08],0.4224347540770216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,9747,351,0.96 [0.77-1.19],0.7037544707710408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,9852,351,1.03 [0.76-1.40],0.8433030882269665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,11354,418,1.06 [0.79-1.42],0.6885849457216717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,9742,342,0.50 [0.13-1.87],0.3022939216700027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,11545,425,1.09 [0.89-1.34],0.3983956033396324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,11096,409,1.05 [0.99-1.13],0.1207701360933582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,9883,350,1.74 [0.93-3.25],0.0850327061376687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,9745,345,1.68 [1.08-2.62],0.0210068734172198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,9777,346,0.99 [0.71-1.39],0.9633128387263472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,9909,351,2.53 [1.32-4.83],0.0049799299084227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,9909,351,1.32 [0.76-2.29],0.3167490661143081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,11311,417,0.91 [0.80-1.03],0.1194079233585278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,11360,416,1.04 [0.95-1.15],0.3698036488636322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,11200,414,1.04 [0.86-1.25],0.6860841514722067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,11483,424,1.07 [0.93-1.24],0.3214870414663678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,11557,426,0.90 [0.77-1.06],0.2074245732036007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,11330,413,1.10 [0.85-1.44],0.4687981097492902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,9893,350,1.40 [0.68-2.89],0.360457192327251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,9893,350,1.30 [0.91-1.86],0.1511231360322506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,11545,425,0.95 [0.84-1.07],0.3972826802384147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,9898,356,1.08 [0.93-1.26],0.3092879914752957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,9768,343,0.91 [0.61-1.35],0.6362184299164169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,9733,342,1.59 [0.75-3.38],0.2311168220202674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,9893,350,1.72 [0.98-3.03],0.0576273307540085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,9747,351,1.05 [0.97-1.13],0.2714007997823848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,9656,340,1.74 [1.25-2.41],0.0010446066031417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,9866,351,1.08 [0.91-1.28],0.3664958892950198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,11164,413,0.91 [0.79-1.05],0.1973323032316875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,11288,412,1.20 [0.90-1.61],0.2076112659418884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,9644,346,1.33 [0.98-1.81],0.0669919590533885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,11429,424,0.73 [0.54-1.00],0.0528463753283839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,11354,418,1.24 [0.86-1.80],0.2565142889520058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,11354,418,0.98 [0.87-1.10],0.7278260678770163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,11289,412,1.04 [0.85-1.27],0.7097267779445366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,9673,340,1.02 [0.78-1.34],0.8613918487007863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,11123,409,0.91 [0.77-1.07],0.245691560522781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,11123,409,1.17 [0.98-1.39],0.0805122073096037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,11410,413,1.02 [0.89-1.16],0.8130674320613078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,9749,352,0.84 [0.69-1.01],0.0675210008294277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,11123,409,1.05 [0.96-1.15],0.2898158498890709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,11410,418,1.01 [0.87-1.16],0.9427268097247132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,9574,343,1.09 [0.94-1.28],0.2590946041474075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,9866,351,1.03 [0.85-1.26],0.734314904655756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,9677,348,1.00 [0.89-1.13],0.9762040631267704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,9874,353,1.06 [0.91-1.24],0.4409700223837702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,9907,357,0.94 [0.76-1.17],0.5893223573806674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,9552,341,0.91 [0.83-1.01],0.0657069045452748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,9565,341,0.94 [0.81-1.08],0.3745766594853393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,9609,341,1.23 [0.99-1.52],0.0568941914566706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,9911,356,0.90 [0.58-1.39],0.6385968054756737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",11430,420,1.07 [0.97-1.19],0.1639263241828076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,9747,351,0.99 [0.76-1.29],0.9504817372681098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,11406,421,1.07 [0.89-1.28],0.4661570995565368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,11447,423,0.85 [0.68-1.05],0.1234628857969096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,11410,418,0.99 [0.75-1.29],0.9151703684908484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,11164,413,0.99 [0.88-1.12],0.8917424891208775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,11395,417,0.97 [0.91-1.05],0.4694149569065317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,11511,427,0.97 [0.74-1.26],0.7969519738352195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,11410,413,0.79 [0.57-1.08],0.1345209594239662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,9624,345,0.87 [0.69-1.09],0.2135465346994983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,11495,426,0.87 [0.66-1.14],0.3072031638238635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,9624,345,0.88 [0.63-1.22],0.4316942035214516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,11431,423,1.09 [0.94-1.27],0.2576019704822181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,11361,418,0.95 [0.79-1.15],0.6168311099183414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,9609,341,1.02 [0.91-1.14],0.734995943285643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,11354,418,1.02 [0.93-1.13],0.6652086651538085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",11164,413,1.06 [0.90-1.24],0.4961837715140637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,11217,413,0.93 [0.79-1.10],0.4104815479394432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,11311,412,1.00 [0.89-1.13],0.9960891361230808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,11447,423,1.05 [0.96-1.13],0.2863816611498097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,9580,341,1.11 [0.87-1.42],0.3998970065347346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,9883,356,1.04 [0.95-1.14],0.3895769989401778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,11217,413,0.94 [0.81-1.10],0.4539976306403114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,11123,409,1.09 [0.87-1.36],0.4400159025689536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,11410,418,0.89 [0.76-1.03],0.1157208055179903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,11123,409,0.83 [0.70-0.98],0.029027729052822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,9580,341,1.02 [0.69-1.50],0.9361367883366803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,9864,357,0.92 [0.77-1.11],0.4043967046054586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,11164,413,0.91 [0.78-1.08],0.2798778326226132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,9644,346,1.04 [0.86-1.26],0.6898706047471486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,11164,413,1.02 [0.90-1.16],0.767629647105251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,9552,341,0.85 [0.69-1.03],0.101451007079894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,9552,341,1.06 [0.85-1.32],0.6203850602023088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,11164,413,1.13 [0.88-1.46],0.3405501556535291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,11410,418,1.02 [0.87-1.20],0.7798313074698242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,9644,346,0.80 [0.66-0.96],0.0178775955038283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,9911,356,1.04 [0.84-1.28],0.7197527573736828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,9580,341,1.09 [0.95-1.25],0.2113720081250465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,9673,340,1.07 [0.95-1.20],0.2949611515225999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,9866,351,0.98 [0.80-1.20],0.8536444341178202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",9552,341,0.89 [0.73-1.09],0.2541036225012749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,11164,413,0.89 [0.74-1.07],0.2042998378073668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,9609,341,0.90 [0.65-1.24],0.5065891687935961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,11511,427,0.91 [0.73-1.12],0.3716068729757709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,11200,414,1.05 [0.82-1.36],0.6790477697499886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,9747,351,1.09 [0.97-1.23],0.1443178655265741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,9866,351,1.07 [0.95-1.20],0.2775075179262367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,9848,355,0.91 [0.68-1.22],0.5384156819901365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,11123,409,1.10 [1.00-1.22],0.0577827737394317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,9864,357,1.14 [0.99-1.31],0.0644848679512158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,9864,357,1.27 [1.06-1.53],0.0101824773178269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,11354,418,0.98 [0.64-1.50],0.9135890451843586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,11164,413,0.94 [0.83-1.06],0.3226998592190203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,9552,341,0.92 [0.75-1.13],0.4120482676993895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,9866,351,1.04 [0.89-1.21],0.6544127376895137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,11511,427,0.72 [0.56-0.95],0.0174962995721025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,11447,423,1.04 [0.82-1.31],0.7652030330769528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,11464,423,0.85 [0.71-1.01],0.0657468010019539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,9609,341,1.03 [0.88-1.22],0.6891422978501576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,11424,423,0.95 [0.83-1.08],0.4089143462934609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,9864,357,1.10 [0.97-1.24],0.1348589548779521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,9574,343,1.06 [0.91-1.23],0.4605747992561595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,9853,353,1.07 [0.97-1.19],0.1944398038169712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,11410,413,1.05 [0.95-1.16],0.3783218088569785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,9574,343,1.23 [0.99-1.53],0.060197960758887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,11429,424,1.02 [0.93-1.11],0.7434827249264144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,9883,356,1.12 [0.95-1.33],0.1786949805655956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,9673,340,1.00 [0.92-1.10],0.94167860615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,11330,413,0.85 [0.74-0.97],0.0161961553696129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",9624,345,1.03 [0.74-1.43],0.863370646318305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',9874,353,1.04 [0.85-1.27],0.704021396392327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,9580,341,0.96 [0.82-1.14],0.6556098751725801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,9673,340,1.06 [0.88-1.29],0.5164320726676976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,9866,351,1.02 [0.81-1.27],0.8780365776769643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,9864,357,1.12 [1.00-1.25],0.0441291035951387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,9624,345,1.07 [0.77-1.49],0.6744205093708329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,11410,413,1.03 [0.90-1.16],0.6963980949055076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],11181,406,1.01 [0.84-1.21],0.9081893784306492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",11395,417,1.10 [0.88-1.39],0.3968093741600713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,9907,357,0.94 [0.79-1.11],0.4590867610694263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,9883,356,0.91 [0.69-1.20],0.5033236897040576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,11123,409,1.00 [0.77-1.30],0.9822969338043668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,11464,426,0.97 [0.86-1.09],0.5966778320106101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,11400,413,0.87 [0.69-1.09],0.2254723505104972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,11400,413,0.90 [0.72-1.13],0.3607879014161782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,9644,346,1.06 [0.86-1.32],0.5835395642689158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,9861,356,1.03 [0.67-1.60],0.8785757989583656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,9644,346,1.05 [0.71-1.55],0.7954567062123298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,9883,356,1.14 [0.83-1.57],0.4228313057139174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,9883,356,1.06 [0.90-1.24],0.4866444901062432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,11429,424,0.95 [0.84-1.06],0.3532556450811268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,11411,415,0.82 [0.59-1.13],0.2198631105075956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPART,Spartin,9673,340,1.07 [0.94-1.22],0.2933330289554197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,9898,356,1.07 [0.78-1.46],0.6706692277093234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,11395,417,0.93 [0.74-1.18],0.5597414162977907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,9673,340,1.32 [1.01-1.71],0.0421697077921251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,11410,418,0.97 [0.85-1.12],0.6963967985621531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,11395,417,0.76 [0.59-0.99],0.0380864763971179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,11511,427,1.08 [0.92-1.27],0.3539446084366605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,9580,341,1.22 [0.96-1.55],0.1105380077486794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,11351,416,1.09 [0.77-1.54],0.6348619460517274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,11447,423,1.02 [0.82-1.26],0.8825968444169366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,9866,351,0.99 [0.93-1.06],0.8416630024734923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,11330,413,1.25 [0.89-1.75],0.1940311274082558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,11404,419,0.84 [0.63-1.10],0.2059553337370881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,11354,409,0.76 [0.58-1.01],0.0549982090818937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,11526,425,0.89 [0.72-1.10],0.2866448813806873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",9609,341,1.09 [0.87-1.36],0.4757333642262144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,9552,341,1.06 [0.91-1.24],0.4368440389463809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,9747,351,1.02 [0.90-1.14],0.8002073583803343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,9874,353,1.10 [0.93-1.30],0.2489620114426379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,11217,413,1.02 [0.93-1.12],0.6374177871986407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",9574,343,1.01 [0.73-1.39],0.960788139117972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,9874,353,0.94 [0.71-1.26],0.6930624087359725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,11411,423,1.06 [0.98-1.13],0.131712194928568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,11354,418,0.91 [0.79-1.05],0.1830147136960683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,11410,418,1.08 [0.98-1.20],0.1133102592117909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,9898,356,1.03 [0.78-1.37],0.8243919382133096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,11164,413,1.01 [0.87-1.18],0.8540797974612525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",9609,341,0.74 [0.53-1.04],0.0799167792605242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,11400,413,1.06 [0.99-1.14],0.107783525896609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,11451,416,1.25 [1.02-1.53],0.031585125487653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,9552,341,1.40 [1.04-1.89],0.0254804240092108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,9866,351,1.07 [0.88-1.31],0.4768369169552173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,9673,340,1.08 [0.89-1.31],0.4474750945322032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",11354,418,1.01 [0.83-1.23],0.929735744709702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",11545,425,1.00 [0.75-1.35],0.9872705195599312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",9609,341,1.05 [0.85-1.29],0.6768382625190346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,9911,356,1.15 [0.80-1.65],0.4639207329481765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,9864,357,1.32 [1.03-1.70],0.0279621970947184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,11311,412,1.08 [0.94-1.24],0.2752771691072693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,9609,341,1.05 [0.92-1.19],0.5009876416447001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,11354,418,1.00 [0.94-1.07],0.9006653861832249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,9552,341,1.07 [0.92-1.23],0.399249256223965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,11520,426,0.95 [0.79-1.15],0.6032553492642475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,11380,417,1.06 [0.73-1.53],0.7631359611479634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,9574,343,0.96 [0.84-1.11],0.6084821089113361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,11373,417,1.07 [0.94-1.22],0.3031773246255013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,11200,414,1.05 [0.93-1.19],0.3961555943849711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,11164,413,1.05 [0.91-1.20],0.5236619479996849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,11410,413,1.08 [0.98-1.19],0.1098372907087762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",9552,341,0.96 [0.86-1.07],0.4748173414595603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,11123,409,1.07 [0.92-1.24],0.3689595554084248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,9644,346,0.95 [0.72-1.24],0.6876573469897576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,9874,353,1.05 [0.80-1.38],0.7102989752586273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,11354,418,1.05 [0.91-1.21],0.531099846049055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,9609,341,1.01 [0.79-1.30],0.928272897948045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,11123,409,1.04 [0.92-1.18],0.511079258551871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,9609,341,0.97 [0.78-1.20],0.7604503524590795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,11410,418,1.15 [0.97-1.36],0.1055766465919744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,9883,356,1.06 [0.93-1.21],0.3511895953835282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,11123,409,1.13 [0.95-1.35],0.1601956800291007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,9866,351,1.26 [1.00-1.58],0.0495904266018294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,11123,409,1.08 [0.96-1.20],0.1958839495564753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,11520,426,1.08 [1.01-1.15],0.0257872282323487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,11410,418,0.93 [0.79-1.08],0.3293848346208132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,9609,341,0.98 [0.84-1.15],0.7922164040437186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,11520,426,1.01 [0.86-1.18],0.9470822309778012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",9883,356,0.87 [0.74-1.03],0.1095510751535978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,11200,414,0.96 [0.80-1.15],0.627825388942684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,11395,417,0.87 [0.64-1.19],0.3888807853077716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,9864,357,1.22 [0.94-1.57],0.1340572545773433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,9629,338,0.93 [0.68-1.28],0.6704499111080786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,9644,346,1.01 [0.86-1.20],0.8753989075031302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,9866,351,1.31 [1.03-1.68],0.0291741975681252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,9673,340,1.15 [0.97-1.38],0.109793515279081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,9574,343,1.02 [0.84-1.22],0.8724721887119563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,9874,353,0.95 [0.71-1.26],0.7025449459265813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,9898,356,1.07 [0.93-1.22],0.3277981758192124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,9747,351,1.06 [0.96-1.16],0.2634467524172645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,11354,418,1.03 [0.95-1.10],0.4894199044642731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,10140,381,1.42 [1.03-1.97],0.0333442445208023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,9864,357,1.36 [1.06-1.74],0.0144674520836099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,11354,418,0.91 [0.70-1.18],0.4612605794656612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,9552,341,1.08 [0.91-1.28],0.3701506817839896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,9881,355,1.02 [0.82-1.28],0.8517200971806598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,11217,413,1.02 [0.91-1.16],0.702277747105941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,9747,351,0.84 [0.68-1.04],0.1061158993011735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,11164,413,1.08 [0.96-1.20],0.1930814238873364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",9644,346,1.03 [0.90-1.17],0.7144781805965827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",9864,357,1.21 [0.94-1.57],0.1421657232764656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,9874,353,1.08 [0.92-1.27],0.3243114621629651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,11164,413,0.93 [0.76-1.14],0.5046220125046345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,11354,418,1.07 [0.97-1.17],0.1663278489775019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,11410,418,1.07 [0.96-1.19],0.20058585983523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,9673,340,1.07 [0.94-1.20],0.3054217460580133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,11330,413,1.03 [0.95-1.13],0.4618308323964567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,11330,413,1.04 [0.93-1.15],0.4995346351175739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,11123,409,1.06 [0.96-1.17],0.2780961656712166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,9644,346,0.98 [0.78-1.23],0.8645873998697833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,11310,411,1.04 [0.95-1.13],0.3807688079088155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,11200,414,1.00 [0.90-1.12],0.9526394677329204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,9716,349,1.15 [0.88-1.50],0.3067640786794999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,11526,425,0.94 [0.70-1.27],0.6957734275278618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,9898,356,1.01 [0.73-1.39],0.9449397294464796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,9747,351,1.02 [0.86-1.21],0.8286993879828579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,9898,356,0.90 [0.65-1.26],0.5433290585620099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,11164,413,0.92 [0.86-0.97],0.0050283703837808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",9644,346,1.03 [0.79-1.34],0.8526000763770434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,9864,357,1.05 [0.92-1.19],0.4769128743917724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,11164,413,1.09 [0.99-1.21],0.0844755959400267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,9580,341,0.77 [0.59-1.01],0.059995429286186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,11429,424,0.91 [0.62-1.34],0.6418862226473812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,9609,341,0.95 [0.66-1.35],0.763141877385815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,9732,349,1.07 [0.97-1.17],0.1807889933828798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,9644,346,0.98 [0.82-1.17],0.8301245689833682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,9747,351,0.94 [0.71-1.24],0.6679618979384928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,9909,351,1.25 [0.78-2.02],0.3503689554556682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,9574,343,0.89 [0.74-1.08],0.2462855538564954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,11349,415,0.91 [0.81-1.02],0.1057982152500722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,11430,420,0.97 [0.83-1.13],0.6907432611744642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,11404,413,0.87 [0.65-1.16],0.3355699129054948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,11377,413,0.77 [0.57-1.04],0.086374820037879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,11394,422,0.93 [0.74-1.16],0.5274669546332496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,11456,415,1.02 [0.81-1.30],0.8371796093929442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,9864,357,1.07 [0.97-1.17],0.1881770395939622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,11410,418,0.89 [0.73-1.09],0.2685300238342907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,11536,426,0.98 [0.79-1.22],0.8813336436994812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,9864,357,0.96 [0.79-1.17],0.7100104433501837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,11338,412,0.76 [0.55-1.07],0.1132123978662105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,9609,341,0.86 [0.54-1.38],0.5338101574743698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,11429,424,0.85 [0.63-1.13],0.261414538320925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,11545,425,0.95 [0.71-1.27],0.7174712653566433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,11387,412,1.00 [0.89-1.13],0.9804058346063422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,9907,357,0.79 [0.52-1.18],0.2464496031389153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,9532,341,1.00 [0.89-1.13],0.9885302745643164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,11410,413,0.99 [0.71-1.37],0.941832564277961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,11395,417,0.80 [0.62-1.03],0.0839384689734099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,11417,414,1.03 [0.85-1.25],0.7741069578614196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,11359,411,0.83 [0.63-1.10],0.1957042868624726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,11200,414,1.00 [0.80-1.26],0.9669893228236544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,9580,341,0.94 [0.84-1.05],0.2773019895612736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,9538,338,0.81 [0.59-1.12],0.2035300247256716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,9838,356,1.09 [0.97-1.22],0.1434669831742397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,11520,426,0.92 [0.67-1.27],0.630668766989224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,11069,407,1.05 [0.98-1.13],0.1477198936202591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,11545,425,0.89 [0.73-1.08],0.2200374310415386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",11145,412,1.17 [0.98-1.39],0.0803083715471699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,9747,351,0.94 [0.70-1.25],0.6595787238591466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,11451,416,0.97 [0.79-1.19],0.788833951535621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,9898,356,1.26 [1.00-1.60],0.0540347270314659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,9874,353,1.11 [0.99-1.24],0.0821659462215976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,11290,408,0.75 [0.54-1.05],0.0940180769440282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,9898,356,0.80 [0.51-1.25],0.3294465937680581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,11447,423,0.99 [0.92-1.05],0.6648458228994865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,11395,417,1.00 [0.80-1.25],0.9995781912114434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,11380,412,0.59 [0.40-0.89],0.0113970371449968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,11429,424,1.05 [0.95-1.16],0.3397460436986217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,9574,343,1.01 [0.78-1.30],0.9691905225658308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",9747,351,1.04 [0.84-1.30],0.7059833689353412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,9609,341,1.11 [0.74-1.65],0.6132266374366793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,9747,351,1.15 [0.73-1.79],0.5493684437734637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,11557,426,1.03 [0.90-1.19],0.6713920293795779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,9609,341,0.99 [0.68-1.43],0.9410793768654042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,9644,346,1.04 [0.86-1.26],0.6903465576870447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,9747,351,0.96 [0.79-1.16],0.6707994923991587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,9580,341,1.01 [0.80-1.27],0.939434372451478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,9580,341,0.97 [0.80-1.17],0.7436575160001104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,9866,351,1.05 [0.95-1.16],0.3327439237316523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,9864,357,1.07 [0.93-1.22],0.3466102234439849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,9624,345,0.97 [0.83-1.15],0.7469049410404947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,9883,356,0.99 [0.80-1.24],0.9421729242479367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,9552,341,0.93 [0.72-1.21],0.5861074658726895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,9574,343,1.11 [0.98-1.26],0.0892322383063033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,9852,351,0.83 [0.62-1.11],0.2161885765532444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,11354,418,0.99 [0.89-1.10],0.8500915901185853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,11271,410,1.15 [0.91-1.46],0.2289431448862365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,11395,417,0.96 [0.86-1.07],0.4374030707555021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,11451,416,0.83 [0.69-1.00],0.0507565911873192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,11177,412,0.76 [0.57-1.02],0.0658139312398746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,9866,351,1.05 [0.87-1.28],0.6022976182886974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,11217,413,1.16 [0.92-1.45],0.2145081135270764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,9673,340,1.11 [0.95-1.30],0.1936650517008247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,11330,413,0.77 [0.58-1.03],0.0772735670412304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,11330,413,0.93 [0.72-1.20],0.5895028910941693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,11430,422,1.03 [0.86-1.23],0.7481054985059176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,11557,426,0.90 [0.71-1.14],0.3800622723751125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,11384,418,0.72 [0.53-0.97],0.0314292414249262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,11429,424,0.83 [0.65-1.06],0.1319542091602376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,11404,419,0.99 [0.75-1.32],0.9703326189146352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,11217,413,1.09 [0.88-1.34],0.4265335964473846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,11404,419,0.94 [0.70-1.25],0.6547266385883415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,9673,340,0.88 [0.68-1.15],0.3637992181315264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,11511,427,1.04 [0.78-1.39],0.7959538578697758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,11395,417,0.69 [0.49-0.95],0.0254113037234719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,11395,417,0.69 [0.52-0.91],0.0092987391390158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,11520,426,0.91 [0.65-1.25],0.5474863087566171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,11536,426,0.73 [0.56-0.95],0.0168793890172578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,11330,413,0.89 [0.75-1.04],0.1408407752435692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,11520,426,0.76 [0.62-0.94],0.0120226509110678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,11330,413,0.93 [0.73-1.19],0.5546836816272909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,11557,426,0.83 [0.59-1.16],0.2729366840245616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,11410,418,1.08 [0.94-1.24],0.2646077716964351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,11557,426,1.06 [0.79-1.43],0.696468583976994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,11447,423,1.10 [0.79-1.52],0.573353404195674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,11524,424,0.76 [0.54-1.07],0.119427489149417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,11330,413,1.04 [0.90-1.20],0.609746540770689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,9911,356,1.04 [0.78-1.38],0.8046736748867536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,9874,353,1.05 [0.94-1.18],0.3549392374054018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,9911,356,0.93 [0.74-1.18],0.5760111928740099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",11200,414,1.02 [0.92-1.14],0.6774995339910628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,9747,351,1.13 [0.86-1.49],0.3710751009430326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,11330,413,1.04 [0.84-1.29],0.6970018129722062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,11395,417,1.02 [0.73-1.44],0.8870930109458051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,9898,356,1.05 [0.93-1.20],0.4295928169760522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,9866,351,1.03 [0.95-1.12],0.4363405186094063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",9552,341,1.12 [0.91-1.37],0.3008419999972045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,9609,341,1.00 [0.88-1.14],0.9895340049670316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,9624,345,1.08 [0.90-1.29],0.3920611577501256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,11123,409,1.15 [0.95-1.39],0.1492985024701466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,9609,341,1.02 [0.90-1.15],0.7687127514133375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,9468,332,1.08 [0.89-1.32],0.4241542324199884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,11200,414,1.18 [0.92-1.52],0.193761579389164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,9644,346,0.98 [0.72-1.33],0.890870523839922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,9644,346,1.00 [0.76-1.31],0.9901695968792336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,9673,340,1.02 [0.92-1.12],0.7493870919388952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,9898,356,0.92 [0.64-1.31],0.6348503969105024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,9580,341,0.89 [0.70-1.13],0.3285104590384214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,11123,409,1.02 [0.90-1.15],0.7626155221024092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,11308,413,0.98 [0.81-1.18],0.8282977001411385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,9747,351,0.88 [0.76-1.02],0.0959173977787921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,11164,413,1.07 [0.87-1.31],0.5414788242104358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,9580,341,0.85 [0.67-1.07],0.1657838968738523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,9552,341,1.09 [0.94-1.27],0.2426952494577014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,11540,425,1.03 [0.87-1.21],0.7475053828564914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,9883,356,1.08 [0.84-1.40],0.5423354814099257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,9609,341,0.75 [0.50-1.12],0.1593339690384597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,11217,413,1.05 [0.92-1.19],0.4720560248904223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,11410,418,1.03 [0.91-1.16],0.6741033950662962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",9609,341,0.92 [0.69-1.22],0.5493292492110722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,9580,341,0.91 [0.72-1.16],0.449402527459152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,9747,351,1.06 [0.94-1.20],0.30706071448469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,9911,356,0.89 [0.78-1.01],0.0614070367057255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,11384,418,0.92 [0.78-1.09],0.3437751309746938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,9907,357,1.03 [0.86-1.24],0.7372171156944912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,11395,417,0.93 [0.72-1.20],0.5751673454042643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,11511,427,1.06 [0.93-1.20],0.4239246016805744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,11410,418,1.10 [0.98-1.24],0.109289303728926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,9726,350,1.05 [0.89-1.22],0.5795068966244009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,9866,351,1.05 [0.96-1.16],0.2728596877638732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,9552,341,1.05 [0.88-1.25],0.5593261963464742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,9644,346,1.08 [0.94-1.24],0.2859375206469139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,11410,418,1.07 [0.97-1.18],0.1969638995126741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,9864,357,1.05 [0.94-1.18],0.3671219570325246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,9580,341,1.16 [0.95-1.41],0.1392110055716125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,9609,341,0.97 [0.84-1.11],0.6421808669356242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,9883,356,1.15 [1.00-1.33],0.0509601824553955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,11410,413,1.03 [0.90-1.17],0.6965540509243935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,11200,414,0.95 [0.82-1.10],0.4909129813125632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,9580,341,1.08 [0.84-1.40],0.5532172371776741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,11200,414,1.47 [1.32-1.63],7.841987118988363e-13
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,9580,341,1.04 [0.84-1.29],0.7244797822215808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,9574,343,1.05 [0.95-1.16],0.3633889048429132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,9866,351,1.03 [0.92-1.14],0.6557354242627158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,9609,341,0.93 [0.72-1.21],0.5930515018320809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,11148,412,1.03 [0.92-1.15],0.6232873893768811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,9644,346,1.26 [1.04-1.52],0.0159603128286591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTN,Titin,9580,341,1.04 [0.91-1.20],0.5459604502377708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,9805,344,1.37 [0.89-2.10],0.1492630955415147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,9574,343,1.19 [0.84-1.70],0.3278796429170878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,9911,356,1.06 [0.94-1.19],0.3369306819317693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,9747,351,1.04 [0.91-1.19],0.5980625303701728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,11330,413,1.06 [0.96-1.17],0.2271166483515017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,9759,353,0.96 [0.76-1.21],0.722303077608526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,11429,424,0.70 [0.52-0.95],0.022052883633011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,11520,426,1.06 [0.94-1.19],0.3638736904441771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,9874,353,1.15 [0.96-1.37],0.1320849106777479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,9558,343,0.97 [0.88-1.08],0.625566864285698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",11395,417,1.11 [0.92-1.33],0.2777478207095653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,11338,412,1.06 [0.93-1.20],0.4045406540738081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,11410,413,0.98 [0.72-1.33],0.8798880797904517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",9609,341,1.15 [0.97-1.36],0.1073857047796271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,11354,418,0.99 [0.77-1.29],0.961730585122508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,9864,357,1.46 [1.05-2.04],0.0261372761795221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,9898,356,1.05 [0.89-1.23],0.5891871671163944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,9609,341,1.08 [0.92-1.28],0.3301223844355121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,9580,341,0.93 [0.75-1.16],0.5208379132226774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,9673,340,1.07 [0.92-1.24],0.3720398276592228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,9866,351,1.03 [0.96-1.11],0.3751522801601497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,9580,341,0.95 [0.85-1.06],0.3745430574135633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,9580,341,0.80 [0.57-1.13],0.2053222259579148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,11330,413,0.90 [0.72-1.14],0.3929859079520217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,11500,424,1.07 [0.91-1.26],0.4289267001214716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,9609,341,1.00 [0.68-1.47],0.9922117103659976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,9552,341,1.07 [0.90-1.29],0.4353189182416771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,9864,357,1.04 [0.78-1.38],0.7810569254699878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,9898,356,0.95 [0.85-1.06],0.3667142937199801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,9574,343,0.93 [0.74-1.16],0.5333157711807379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,9725,351,1.01 [0.83-1.23],0.9297800272489264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,9673,340,1.09 [0.93-1.26],0.2943931960243918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,9644,346,1.07 [0.92-1.24],0.3828001728535838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,11354,418,1.01 [0.92-1.11],0.8276109510474716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,9864,357,1.11 [0.97-1.27],0.1416352910992148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,9874,353,0.92 [0.68-1.27],0.6254580375790875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,9580,341,1.02 [0.91-1.15],0.6883731663765772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,11200,414,1.08 [0.98-1.18],0.1058220325697973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,11123,409,0.99 [0.83-1.18],0.925184774876558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,11200,414,0.91 [0.76-1.09],0.2917031706381605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,9609,341,1.03 [0.92-1.16],0.6071986020460476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,11410,418,1.07 [0.97-1.19],0.187314675842511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,11237,408,0.87 [0.63-1.21],0.4191810754779996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,9907,357,1.06 [0.93-1.21],0.3951124465103951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,11354,418,1.00 [0.64-1.56],0.997364544524045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,9574,343,1.09 [0.98-1.21],0.1024123658128667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,11439,415,0.56 [0.40-0.79],0.000844529708886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,11520,426,0.80 [0.60-1.07],0.1344785209912117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,9552,341,1.08 [0.96-1.21],0.2018163160428117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,11519,426,1.04 [0.90-1.21],0.565694982973094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,9609,341,0.63 [0.44-0.90],0.012030709995138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,11429,424,0.99 [0.86-1.16],0.9388929588635984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,11538,426,1.04 [0.83-1.30],0.7447022564779834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,9883,356,1.19 [0.85-1.68],0.3117045516986135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,11200,414,1.06 [0.98-1.14],0.1608409825436257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,9624,345,1.08 [0.73-1.59],0.7163516898027262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,9898,356,1.23 [0.94-1.61],0.137181020063213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,11354,418,0.90 [0.80-1.02],0.1117494964064631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,9907,357,0.87 [0.76-0.99],0.0407474556129101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,11354,418,0.93 [0.78-1.12],0.4496094285672071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,9747,351,1.12 [0.97-1.30],0.1244269717798486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,11354,418,1.04 [0.93-1.16],0.4941594605463331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,9864,357,1.09 [0.98-1.20],0.1167905553201235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,11354,418,1.06 [0.95-1.18],0.3235883014750764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,9864,357,1.16 [0.89-1.52],0.2576718751239587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,9580,341,1.00 [0.73-1.37],0.9966539152365068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,9864,357,1.02 [0.85-1.22],0.8304785566245758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,11380,417,0.81 [0.67-0.98],0.0285242736504785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,11393,413,1.05 [0.92-1.21],0.4694454604558025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,9874,353,0.93 [0.72-1.21],0.6118748100948342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,11164,413,0.89 [0.74-1.07],0.205011914973675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,9747,351,1.04 [0.81-1.33],0.7657082919238811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,11200,414,1.02 [0.87-1.19],0.8062109951284107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,11520,426,1.02 [0.91-1.15],0.731739096936751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,11123,409,0.95 [0.71-1.25],0.6962238938135183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,9673,340,1.15 [0.97-1.37],0.1081182305193648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,11500,427,0.97 [0.80-1.19],0.798005063719577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,9552,341,0.98 [0.85-1.12],0.7426404431525789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,11290,411,0.92 [0.73-1.16],0.4771443046200427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,9883,356,0.85 [0.66-1.10],0.2166253957537268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,11545,425,0.95 [0.85-1.07],0.4080704458996396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",11395,417,0.82 [0.65-1.02],0.0790054331297639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,11217,413,1.13 [1.00-1.28],0.0554131175454316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,11200,414,1.07 [0.98-1.17],0.128301830796131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,11164,413,1.08 [0.97-1.19],0.1478453663473618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,9874,353,1.07 [0.94-1.22],0.2845612476055306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,9609,341,0.98 [0.82-1.17],0.8308425965088926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,9864,357,1.19 [0.94-1.52],0.1497934616458523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,9655,351,1.13 [0.95-1.35],0.1632160675497146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,11487,426,1.06 [0.93-1.22],0.3865042677144091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,10824,401,0.95 [0.73-1.23],0.6862302569758728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",11288,412,0.98 [0.79-1.22],0.8511552954122619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",11404,419,1.00 [0.77-1.31],0.9748332154121802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,11511,427,1.01 [0.78-1.31],0.922162010839878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,11217,413,1.41 [1.03-1.91],0.0299512927056887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,11330,413,1.10 [0.93-1.29],0.274470934927081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,11511,427,0.83 [0.70-0.98],0.0271650908038522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,11485,421,0.91 [0.70-1.18],0.4674740033386289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,9609,341,1.08 [0.91-1.28],0.4024185495947678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,11429,424,1.00 [0.93-1.08],0.9807007019119096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,11164,413,1.08 [0.85-1.36],0.5313914603745714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,9874,353,0.84 [0.57-1.24],0.3774180732673725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",9866,351,1.03 [0.96-1.10],0.4341183410103008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,11354,418,1.02 [0.95-1.10],0.5999098444619262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,9864,357,1.38 [1.03-1.84],0.0288426685605894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,9580,341,0.97 [0.82-1.15],0.7078760255435711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,11217,413,1.01 [0.92-1.12],0.801539430485184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,9673,340,1.08 [0.94-1.25],0.2529881885517145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,9609,341,1.38 [0.98-1.95],0.0671134550311394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,9609,341,0.89 [0.68-1.16],0.3965831718149495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,11123,409,1.12 [1.00-1.26],0.0576111053069581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,11200,414,1.03 [0.84-1.26],0.7647440790948103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,9580,341,0.99 [0.84-1.18],0.9463594252642584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,9866,351,1.04 [0.93-1.16],0.5407555025442865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,9874,353,1.03 [0.77-1.36],0.8594569189365643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,9609,341,0.87 [0.63-1.19],0.3703935487775491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,9747,351,0.97 [0.82-1.15],0.7157148639736927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,9864,357,0.93 [0.81-1.06],0.2661342765215999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,9866,351,1.08 [0.93-1.25],0.2978830113009408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,9864,357,0.97 [0.80-1.18],0.7394316935588718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,9624,345,1.00 [0.96-1.04],0.9955223393626682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,9552,341,0.95 [0.67-1.34],0.7722879199752168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,9574,343,0.98 [0.87-1.10],0.7236575399481155
